HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
165668.0,294776,2107-10-31 06:38:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Cholangitis
   24 Hour Events:
   - pt with elevated BP into the 190-200 --> given hydral 5mg and
   returned to 110-140's.
   - Pt Hct 32.2 --> 27.4 --> 26.7
   - pt had large maroon stool overnight
   - pt transfused 1U pRBC
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ciprofloxacin - [**2107-10-30**] 06:02 PM
   Metronidazole - [**2107-10-31**] 02:06 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-10-30**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever, no light-headness, dizziness
   Eyes: No(t)  Blurry vision
   Cardiovascular: No(t) Chest pain, No(t) Palpitations
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis, pt
   with 1 episode of maroon stools
   Genitourinary: No(t) Dysuria
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-10-31**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 72 (60 - 74) bpm
   BP: 144/22(53) {94/22(53) - 223/74(108)} mmHg
   RR: 19 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AV Paced
           Total In:
                                                                    990 mL
                                                                    413 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                    390 mL
                                                                    164 mL
   Blood products:
   248 mL
   Total out:
                                                                    350 mL
                                                                    300 mL
   Urine:
                                                                    350 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    640 mL
                                                                    113 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender:
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, No(t) Sedated, Tone: Not assessed
   Labs / Radiology
   163 K/uL
   8.9 g/dL
   122 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.9 mEq/L
   30 mg/dL
   109 mEq/L
   136 mEq/L
   26.7 %
   11.5 K/uL
        [image002.jpg]
                             [**2107-10-30**]  04:13 PM
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
   WBC
   16.1
   11.5
   Hct
   32.2
   27.4
   26.7
   Plt
   170
   163
   Cr
   0.9
   1.0
   Glucose
   144
   122
   Other labs: PT / PTT / INR:14.6/24.4/1.3, ALT / AST:121/95, Alk Phos /
   T Bili:149/1.5, Amylase / Lipase:122/200, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:176 IU/L,
   Ca++:8.4 mg/dL, Mg++:1.5 mg/dL, PO4:3.0 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   # Cholangitis: s/p ERCP with a sphincterotomy and  stent placment for
   cholangitis, stones in the common bile duct.  Had biliary ductal
   dilation. Pt has been afebrile and hemodynamically stable.  No evidence
   of post-ERCP pancreatitis
   -continue antibiotics cipro / flagyl --> t/d with surgery regarding
   length of treatment
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # GI BLEED: s/p sphincterotomy with roughly 200cc of bleeding, bleeding
   controlled locally during ERCP.  The patient had episode of large
   maroon BM, with SBP into the 90-100's.  Pt was transfused 1U pRBC due
   to progressively decreasing Hct.  Pt
s Hct did not increase
   appropriately after 1U. ERCP fellow notified.
   - will transfuse 1U pRBC
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - keep NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - f/u ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies that were sent
   - will trend LFTs and pancreatic enzymes
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # HTN: Pt was  hypertensive and given 5mg hydral, but asymptomatic.
   Will avoid hydral and give Beta blocker for BP control.  Home med is
   atenolol, but will use lopressor for shorting acting [**Doctor Last Name 23**] given risk
   of bleed.
   -Will cont home diovan
   - start lopressor 12.5mg [**Hospital1 **]
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  Will recheck Hct after 1U transfusion and check for signs of
   bleeding
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2107-10-31**] 04:16 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Cholangitis
   24 Hour Events:
   - pt with elevated BP into the 190-200 --> given hydral 5mg and
   returned to 110-140's.
   - Pt Hct 32.2 --> 27.4 --> 26.7
   - pt had large maroon stool overnight
   - pt transfused 1U pRBC
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ciprofloxacin - [**2107-10-30**] 06:02 PM
   Metronidazole - [**2107-10-31**] 02:06 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-10-30**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever, no light-headness, dizziness
   Eyes: No(t)  Blurry vision
   Cardiovascular: No(t) Chest pain, No(t) Palpitations
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis, pt
   with 1 episode of maroon stools
   Genitourinary: No(t) Dysuria
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-10-31**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 72 (60 - 74) bpm
   BP: 144/22(53) {94/22(53) - 223/74(108)} mmHg
   RR: 19 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AV Paced
           Total In:
                                                                    990 mL
                                                                    413 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                    390 mL
                                                                    164 mL
   Blood products:
   248 mL
   Total out:
                                                                    350 mL
                                                                    300 mL
   Urine:
                                                                    350 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    640 mL
                                                                    113 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender:
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, No(t) Sedated, Tone: Not assessed
   Labs / Radiology
   163 K/uL
   8.9 g/dL
   122 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.9 mEq/L
   30 mg/dL
   109 mEq/L
   136 mEq/L
   26.7 %
   11.5 K/uL
        [image002.jpg]
                             [**2107-10-30**]  04:13 PM
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
   WBC
   16.1
   11.5
   Hct
   32.2
   27.4
   26.7
   Plt
   170
   163
   Cr
   0.9
   1.0
   Glucose
   144
   122
   Other labs: PT / PTT / INR:14.6/24.4/1.3, ALT / AST:121/95, Alk Phos /
   T Bili:149/1.5, Amylase / Lipase:122/200, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:176 IU/L,
   Ca++:8.4 mg/dL, Mg++:1.5 mg/dL, PO4:3.0 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   # Cholangitis: s/p ERCP with a sphincterotomy and  stent placment for
   cholangitis, stones in the common bile duct.  Had biliary ductal
   dilation. Pt has been afebrile and hemodynamically stable.  No evidence
   of post-ERCP pancreatitis
   -continue antibiotics cipro / flagyl --> t/d with surgery regarding
   length of treatment
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # GI BLEED: s/p sphincterotomy with roughly 200cc of bleeding, bleeding
   controlled locally during ERCP.  The patient had episode of large
   maroon BM, with SBP into the 90-100's.  Pt was transfused 1U pRBC due
   to progressively decreasing Hct.  Pt
s Hct did not increase
   appropriately after 1U. ERCP fellow notified.
   - will transfuse 1U pRBC
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - keep NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - f/u ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies that were sent
   - will trend LFTs and pancreatic enzymes
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # HTN: Pt was  hypertensive and given 5mg hydral, but asymptomatic.
   Will avoid hydral and give Beta blocker for BP control.  Home med is
   atenolol, but will use lopressor for shorting acting [**Doctor Last Name 23**] given risk
   of bleed.
   -Will cont home diovan
   - start lopressor 12.5mg [**Hospital1 **]
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  Will recheck Hct after 1U transfusion and check for signs of
   bleeding
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2107-10-31**] 04:16 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following is a summary of the patient's health progress in the ICU:

The patient is an 87-year-old female who was admitted to the ICU with cholangitis following an ERCP procedure with sphincterotomy and stent placement. The patient had a large amount of bleeding during the procedure, which was locally controlled. The patient was transfused 1U of packed red blood cells (pRBC) due to a decreasing hemoglobin level, but the hemoglobin level did not increase appropriately.

The patient's vital signs are stable, with a heart rate of 72 beats per minute, blood pressure of 144/22 mmHg, and oxygen saturation of 97%. The patient is hemodynamically stable, but has a risk of re-bleeding.

The patient's laboratory results show a decreasing hemoglobin level, with a current level of 26.7%. The patient's white blood cell count is elevated, with a current level of 16.1. The patient's liver function tests (LFTs) are trending down, with a current level of 121 IU/L for ALT and 95 IU/L for AST.

The patient's plan includes continuing antibiotics, remaining NPO, and monitoring the patient's hemoglobin level and bleeding status. The patient is also being monitored for signs of post-ERCP pancreatitis and for any changes in the patient's bleeding status.

Potential medical complications that can arise include:

1. Re-bleeding: The patient has a risk of re-bleeding due to the sphincterotomy procedure and the patient's decreased hemoglobin level.
2. Infection: The patient has cholangitis, which can lead to sepsis and multi-organ failure if not treated promptly and effectively.
3. Pancreatitis: The patient has a risk of developing post-ERCP pancreatitis, which can lead to severe abdominal pain, nausea, and vomiting.
4. Hypovolemic shock: The patient has a risk of developing hypovolemic shock due to the patient's decreased blood volume and the patient's risk of re-bleeding.
5. Respiratory failure: The patient has a risk of developing respiratory failure due to the patient's decreased oxygen saturation and the patient's risk of developing pneumonia.

It is essential to monitor the patient's vital signs, laboratory results, and bleeding status closely to prevent these potential complications and ensure the patient's optimal care."
165668.0,294776,2107-10-31 06:38:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Cholangitis
   24 Hour Events:
   - pt with elevated BP into the 190-200 --> given hydral 5mg and
   returned to 110-140's.
   - Pt Hct 32.2 --> 27.4 --> 26.7
   - pt had large maroon stool overnight
   - pt transfused 1U pRBC
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ciprofloxacin - [**2107-10-30**] 06:02 PM
   Metronidazole - [**2107-10-31**] 02:06 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-10-30**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever, no light-headness, dizziness
   Eyes: No(t)  Blurry vision
   Cardiovascular: No(t) Chest pain, No(t) Palpitations
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis, pt
   with 1 episode of maroon stools
   Genitourinary: No(t) Dysuria
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-10-31**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 72 (60 - 74) bpm
   BP: 144/22(53) {94/22(53) - 223/74(108)} mmHg
   RR: 19 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AV Paced
           Total In:
                                                                    990 mL
                                                                    413 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                    390 mL
                                                                    164 mL
   Blood products:
   248 mL
   Total out:
                                                                    350 mL
                                                                    300 mL
   Urine:
                                                                    350 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    640 mL
                                                                    113 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender:
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, No(t) Sedated, Tone: Not assessed
   Labs / Radiology
   163 K/uL
   8.9 g/dL
   122 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.9 mEq/L
   30 mg/dL
   109 mEq/L
   136 mEq/L
   26.7 %
   11.5 K/uL
        [image002.jpg]
                             [**2107-10-30**]  04:13 PM
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
   WBC
   16.1
   11.5
   Hct
   32.2
   27.4
   26.7
   Plt
   170
   163
   Cr
   0.9
   1.0
   Glucose
   144
   122
   Other labs: PT / PTT / INR:14.6/24.4/1.3, ALT / AST:121/95, Alk Phos /
   T Bili:149/1.5, Amylase / Lipase:122/200, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:176 IU/L,
   Ca++:8.4 mg/dL, Mg++:1.5 mg/dL, PO4:3.0 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   # Cholangitis: s/p ERCP with a sphincterotomy and  stent placment for
   cholangitis, stones in the common bile duct.  Had biliary ductal
   dilation. Pt has been afebrile and hemodynamically stable.  No evidence
   of post-ERCP pancreatitis
   -continue antibiotics cipro / flagyl --> t/d with surgery regarding
   length of treatment
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -culture if spikes, follow wbc and fever curve, obtain OSH cultures if
   any
   .
   # GI BLEED: s/p sphincterotomy with roughly 200cc of bleeding, bleeding
   controlled locally during ERCP but per ERCP attending the patient is at
   high risk to re bleed.  The patient had episode of large maroon BM,
   with SBP into the 90-100's.  Pt was transfused 1U pRBC. ERCP fellow
   notified.
   - check post-transfusion Hct
   - if active evidence of bleed is not apparent within 24 hours then risk
   is bleeding is low
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   -call ERCP if rebleeds
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies that were sent
   - will trend LFTs and pancreatic enzymes
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # HTN: Pt was  hypertensive and given 5mg hydral, but asymptomatic.
   Will cont home atenolol and diovan
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO for now, PPI
   - f/u with surgery regarding when to start diet
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  [**Month (only) 11**] go to floor if HD stable and no active signs of bleeding.
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2107-10-31**] 04:16 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Cholangitis
   24 Hour Events:
   - pt with elevated BP into the 190-200 --> given hydral 5mg and
   returned to 110-140's.
   - Pt Hct 32.2 --> 27.4 --> 26.7
   - pt had large maroon stool overnight
   - pt transfused 1U pRBC
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ciprofloxacin - [**2107-10-30**] 06:02 PM
   Metronidazole - [**2107-10-31**] 02:06 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-10-30**] 08:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever, no light-headness, dizziness
   Eyes: No(t)  Blurry vision
   Cardiovascular: No(t) Chest pain, No(t) Palpitations
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis, pt
   with 1 episode of maroon stools
   Genitourinary: No(t) Dysuria
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-10-31**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 72 (60 - 74) bpm
   BP: 144/22(53) {94/22(53) - 223/74(108)} mmHg
   RR: 19 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AV Paced
           Total In:
                                                                    990 mL
                                                                    413 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                    390 mL
                                                                    164 mL
   Blood products:
   248 mL
   Total out:
                                                                    350 mL
                                                                    300 mL
   Urine:
                                                                    350 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    640 mL
                                                                    113 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: Systolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender:
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, No(t) Sedated, Tone: Not assessed
   Labs / Radiology
   163 K/uL
   8.9 g/dL
   122 mg/dL
   1.0 mg/dL
   17 mEq/L
   3.9 mEq/L
   30 mg/dL
   109 mEq/L
   136 mEq/L
   26.7 %
   11.5 K/uL
        [image002.jpg]
                             [**2107-10-30**]  04:13 PM
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
   WBC
   16.1
   11.5
   Hct
   32.2
   27.4
   26.7
   Plt
   170
   163
   Cr
   0.9
   1.0
   Glucose
   144
   122
   Other labs: PT / PTT / INR:14.6/24.4/1.3, ALT / AST:121/95, Alk Phos /
   T Bili:149/1.5, Amylase / Lipase:122/200, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:176 IU/L,
   Ca++:8.4 mg/dL, Mg++:1.5 mg/dL, PO4:3.0 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   # Cholangitis: s/p ERCP with a sphincterotomy and  stent placment for
   cholangitis, stones in the common bile duct.  Had biliary ductal
   dilation. Pt has been afebrile and hemodynamically stable.  No evidence
   of post-ERCP pancreatitis
   -continue antibiotics cipro / flagyl --> t/d with surgery regarding
   length of treatment
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -culture if spikes, follow wbc and fever curve, obtain OSH cultures if
   any
   .
   # GI BLEED: s/p sphincterotomy with roughly 200cc of bleeding, bleeding
   controlled locally during ERCP but per ERCP attending the patient is at
   high risk to re bleed.  The patient had episode of large maroon BM,
   with SBP into the 90-100's.  Pt was transfused 1U pRBC. ERCP fellow
   notified.
   - check post-transfusion Hct
   - if active evidence of bleed is not apparent within 24 hours then risk
   is bleeding is low
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   -call ERCP if rebleeds
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies that were sent
   - will trend LFTs and pancreatic enzymes
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # HTN: Pt was  hypertensive and given 5mg hydral, but asymptomatic.
   Will cont home atenolol and diovan
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO for now, PPI
   - f/u with surgery regarding when to start diet
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  [**Month (only) 11**] go to floor if HD stable and no active signs of bleeding.
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2107-10-31**] 04:16 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 87-year-old female admitted to the ICU with cholangitis following ERCP with sphincterotomy and stent placement. She had a significant episode of bleeding during ERCP, which was locally controlled, but is at high risk for re-bleeding. She was transfused 1U of packed red blood cells and is being closely monitored. Her laboratory results show a drop in hemoglobin levels and a slight increase in blood pressure. She is currently receiving antibiotics and is being monitored for signs of post-ERCP pancreatitis.

Potential Medical Complications:

1. Re-bleeding: The patient is at high risk for re-bleeding due to the sphincterotomy and stent placement. Close monitoring of vital signs and laboratory results is essential to detect any signs of bleeding.
2. Infection: The patient has cholangitis, which increases her risk of developing an infection. Close monitoring of vital signs, laboratory results, and imaging studies is essential to detect any signs of infection.
3. Pancreatitis: The patient is at risk for developing post-ERCP pancreatitis, which can lead to severe abdominal pain, nausea, and vomiting.
4. Electrolyte imbalance: The patient's laboratory results show an increase in sodium and potassium levels, which may indicate an electrolyte imbalance. Close monitoring of electrolyte levels is essential to prevent complications.
5. Kidney injury: The patient's laboratory results show an increase in creatinine levels, which may indicate kidney injury. Close monitoring of kidney function is essential to prevent complications.
6. Respiratory complications: The patient's respiratory status is stable, but close monitoring is essential to detect any signs of respiratory compromise.
7. Cardiovascular complications: The patient's blood pressure is stable, but close monitoring is essential to detect any signs of cardiovascular compromise.

Recommendations:

1. Continue antibiotics and monitor for signs of infection.
2. Monitor for signs of re-bleeding and transfuse as necessary.
3. Monitor for signs of post-ERCP pancreatitis and provide supportive care as necessary.
4. Monitor electrolyte levels and provide replacement therapy as necessary.
5. Monitor kidney function and provide supportive care as necessary.
6. Monitor respiratory status and provide supportive care as necessary.
7. Monitor cardiovascular status and provide supportive care as necessary.

It is essential to closely monitor the patient's vital signs, laboratory results, and imaging studies to detect any signs of complications and provide timely interventions to prevent adverse outcomes."
165668.0,294776,2107-11-01 07:24:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Transfused 1u PRBC during the day. ~400 cc with hct to 23.4,
   transfused 2u PRBC
   - Continued to have melanotic stools. 10p - large melanotic stool .  Pt
   also lost conciousness on the commode .
   - Per GI, clears today, NPO at midnight with possible endoscopy
   tomorrow
   - Switched to metoprolol tid for hypertension.  Hypertensive this AM up
   to 200s/50s, received labetolol 10 mg IV x2.
   - This AM continues to have melanotic stool now with coffee gound
   emesis
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ciprofloxacin - [**2107-10-31**] 07:45 PM
   Metronidazole - [**2107-11-1**] 12:11 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-10-31**] 07:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Cardiovascular: No(t) Chest pain, No(t) Palpitations
   Respiratory: No(t) Cough, No(t) Dyspnea
   Gastrointestinal: Abdominal pain, No(t) Nausea, No(t) Emesis, Diarrhea
   Neurologic: No(t) Headache
   Flowsheet Data as of  [**2107-11-1**] 07:23 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 74 (61 - 82) bpm
   BP: 202/67(96) {96/39(56) - 202/85(96)} mmHg
   RR: 19 (15 - 26) insp/min
   SpO2: 99%
   Heart rhythm: AV Paced
           Total In:
                                                                  1,784 mL
                                                                    622 mL
   PO:
                                                                    120 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    945 mL
                                                                    169 mL
   Blood products:
                                                                    719 mL
                                                                    403 mL
   Total out:
                                                                  1,200 mL
                                                                    190 mL
   Urine:
                                                                    450 mL
                                                                    180 mL
   NG:
   10 mL
   Stool:
                                                                    750 mL
   Drains:
   Balance:
                                                                    584 mL
                                                                    432 mL
   Respiratory support
   SpO2: 99%
   ABG: ///18/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal),  RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Bowel sounds present, No(t) Distended, Tender: lower
   abdomin
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   132 K/uL
   11.0 g/dL
   192 mg/dL
   1.0 mg/dL
   18 mEq/L
   4.0 mEq/L
   48 mg/dL
   112 mEq/L
   138 mEq/L
   30.8 %
   9.3 K/uL
        [image002.jpg]
                             [**2107-10-30**]  04:13 PM
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
                             [**2107-10-31**]  07:59 AM
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
   WBC
   16.1
   11.5
   9.3
   Hct
   32.2
   27.4
   26.7
   25.8
   27.7
   24.1
   23.4
   30.8
   Plt
   170
   163
   132
   Cr
   0.9
   1.0
   1.0
   Glucose
   144
   122
   192
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:70/56, Alk Phos / T
   Bili:136/4.5, Amylase / Lipase:47/54, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:175 IU/L,
   Ca++:7.8 mg/dL, Mg++:1.5 mg/dL, PO4:3.2 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
    # GI BLEED: s/p ERCP and sphincterotomy.  The patient had continued
   episodes of [**Last Name (un) 1165**]/bloody stools.  Pt was transfused 3U pRBC due to
   progressively decreasing Hct. Today Hct is 30.8. ERCP aware.  Currently
   hemodynamically stable and pressures have been elevated.
   - f/u ERCP regarding taking patient back to the OR for resolution of
   bleeding site.
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - allow sips per ERCP
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   # Cholangitis: s/p ERCP with a sphincterotomy and  stent placment for
   cholangitis, stones in the common bile duct.  Had biliary ductal
   dilation. Pt has been afebrile and hemodynamically stable. LFT are
   trending down, but TBili has increased to 4.5 No evidence of post-ERCP
   pancreatitis
   - check direct bili levels
   -continue antibiotics cipro / flagyl
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 3 yesterday and
   this AM, pt asymptomatic.   Home med is atenolol, but will use
   lopressor for shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Will cont home diovan
   - Inc opressor 12.5mg TID to 25mg
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-1**] 12:01 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Transfused 1u PRBC during the day. ~400 cc with hct to 23.4,
   transfused 2u PRBC
   - Continued to have melanotic stools. 10p - large melanotic stool .  Pt
   also lost conciousness on the commode .
   - Per GI, clears today, NPO at midnight with possible endoscopy
   tomorrow
   - Switched to metoprolol tid for hypertension.  Hypertensive this AM up
   to 200s/50s, received labetolol 10 mg IV x2.
   - This AM continues to have melanotic stool now with coffee gound
   emesis
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ciprofloxacin - [**2107-10-31**] 07:45 PM
   Metronidazole - [**2107-11-1**] 12:11 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-10-31**] 07:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Cardiovascular: No(t) Chest pain, No(t) Palpitations
   Respiratory: No(t) Cough, No(t) Dyspnea
   Gastrointestinal: Abdominal pain, No(t) Nausea, No(t) Emesis, Diarrhea
   Neurologic: No(t) Headache
   Flowsheet Data as of  [**2107-11-1**] 07:23 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 74 (61 - 82) bpm
   BP: 202/67(96) {96/39(56) - 202/85(96)} mmHg
   RR: 19 (15 - 26) insp/min
   SpO2: 99%
   Heart rhythm: AV Paced
           Total In:
                                                                  1,784 mL
                                                                    622 mL
   PO:
                                                                    120 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    945 mL
                                                                    169 mL
   Blood products:
                                                                    719 mL
                                                                    403 mL
   Total out:
                                                                  1,200 mL
                                                                    190 mL
   Urine:
                                                                    450 mL
                                                                    180 mL
   NG:
   10 mL
   Stool:
                                                                    750 mL
   Drains:
   Balance:
                                                                    584 mL
                                                                    432 mL
   Respiratory support
   SpO2: 99%
   ABG: ///18/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal),  RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Bowel sounds present, No(t) Distended, Tender: lower
   abdomin
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   132 K/uL
   11.0 g/dL
   192 mg/dL
   1.0 mg/dL
   18 mEq/L
   4.0 mEq/L
   48 mg/dL
   112 mEq/L
   138 mEq/L
   30.8 %
   9.3 K/uL
        [image002.jpg]
                             [**2107-10-30**]  04:13 PM
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
                             [**2107-10-31**]  07:59 AM
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
   WBC
   16.1
   11.5
   9.3
   Hct
   32.2
   27.4
   26.7
   25.8
   27.7
   24.1
   23.4
   30.8
   Plt
   170
   163
   132
   Cr
   0.9
   1.0
   1.0
   Glucose
   144
   122
   192
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:70/56, Alk Phos / T
   Bili:136/4.5, Amylase / Lipase:47/54, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:175 IU/L,
   Ca++:7.8 mg/dL, Mg++:1.5 mg/dL, PO4:3.2 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
    # GI BLEED: s/p ERCP and sphincterotomy.  The patient had continued
   episodes of [**Last Name (un) 1165**]/bloody stools.  Pt was transfused 3U pRBC due to
   progressively decreasing Hct. Today Hct is 30.8. ERCP aware.  Currently
   hemodynamically stable and pressures have been elevated.
   - f/u ERCP regarding taking patient back to the OR for resolution of
   bleeding site.
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - allow sips per ERCP
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   # Cholangitis: s/p ERCP with a sphincterotomy and  stent placment for
   cholangitis, stones in the common bile duct.  Had biliary ductal
   dilation. Pt has been afebrile and hemodynamically stable. LFT are
   trending down, but TBili has increased to 4.5 No evidence of post-ERCP
   pancreatitis
   - check direct bili levels
   -continue antibiotics cipro / flagyl
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 3 yesterday and
   this AM, pt asymptomatic.   Home med is atenolol, but will use
   lopressor for shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Will cont home diovan
   - Inc opressor 12.5mg TID to 25mg
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-1**] 12:01 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 87-year-old female who was admitted to the ICU for further observation after undergoing ERCP and sphincterotomy for cholangitis and sphincterotomy bleeding. The patient has continued to have episodes of melena and hematochezia, and has required transfusions of packed red blood cells. The patient's hemoglobin level is currently 30.8, and her blood pressure is elevated.

The patient's laboratory results show evidence of cholangitis, with elevated liver enzymes and bilirubin levels. The patient's platelet count is low, and her international normalized ratio (INR) is elevated.

The patient's medical history includes hypertension, hyperlipidemia, diabetes, and a b12 deficiency. The patient is currently taking medications for hypertension, hyperlipidemia, and diabetes, and is also receiving antibiotics for cholangitis.

The patient's plan of care includes:

* Transfusion of packed red blood cells as needed to maintain a hemoglobin level of 25 or higher
* Maintenance of active type and screen
* Allowance of sips and oral medications as tolerated
* Hemodynamic monitoring
* Use of 2 large bore IVs
* Hold of sc heparin given risk of bleeding
* Administration of IV proton pump inhibitor (PPI)
* Monitoring of liver enzymes and bilirubin levels
* Follow-up with ERCP regarding possible return to the operating room for resolution of bleeding site

Potential medical complications that may arise include:

* Continued bleeding from the sphincterotomy site
* Development of pancreatitis
* Progression of cholangitis
* Hypovolemic shock due to blood loss
* Hypertensive crisis due to uncontrolled hypertension
* Hyperglycemia due to uncontrolled diabetes
* Dehydration due to decreased oral intake
* Pneumonia due to prolonged hospitalization and use of invasive devices

The patient's code status is DNR/DNI, and her disposition is ICU level of care."
165668.0,294776,2107-11-01 07:24:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Transfused 1u PRBC during the day. ~400 cc with hct to 23.4,
   transfused 2u PRBC
   - Continued to have melanotic stools. 10p - large melanotic stool .  Pt
   also lost conciousness on the commode .
   - Per GI, clears today, NPO at midnight with possible endoscopy
   tomorrow
   - Switched to metoprolol tid for hypertension.  Hypertensive this AM up
   to 200s/50s, received labetolol 10 mg IV x2.
   - This AM continues to have melanotic stool now with coffee gound
   emesis
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ciprofloxacin - [**2107-10-31**] 07:45 PM
   Metronidazole - [**2107-11-1**] 12:11 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-10-31**] 07:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Cardiovascular: No(t) Chest pain, No(t) Palpitations
   Respiratory: No(t) Cough, No(t) Dyspnea
   Gastrointestinal: Abdominal pain, No(t) Nausea, No(t) Emesis, Diarrhea
   Neurologic: No(t) Headache
   Flowsheet Data as of  [**2107-11-1**] 07:23 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 74 (61 - 82) bpm
   BP: 202/67(96) {96/39(56) - 202/85(96)} mmHg
   RR: 19 (15 - 26) insp/min
   SpO2: 99%
   Heart rhythm: AV Paced
           Total In:
                                                                  1,784 mL
                                                                    622 mL
   PO:
                                                                    120 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    945 mL
                                                                    169 mL
   Blood products:
                                                                    719 mL
                                                                    403 mL
   Total out:
                                                                  1,200 mL
                                                                    190 mL
   Urine:
                                                                    450 mL
                                                                    180 mL
   NG:
   10 mL
   Stool:
                                                                    750 mL
   Drains:
   Balance:
                                                                    584 mL
                                                                    432 mL
   Respiratory support
   SpO2: 99%
   ABG: ///18/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal),  RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Bowel sounds present, No(t) Distended, Tender: lower
   abdomin
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   132 K/uL
   11.0 g/dL
   192 mg/dL
   1.0 mg/dL
   18 mEq/L
   4.0 mEq/L
   48 mg/dL
   112 mEq/L
   138 mEq/L
   30.8 %
   9.3 K/uL
        [image002.jpg]
                             [**2107-10-30**]  04:13 PM
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
                             [**2107-10-31**]  07:59 AM
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
   WBC
   16.1
   11.5
   9.3
   Hct
   32.2
   27.4
   26.7
   25.8
   27.7
   24.1
   23.4
   30.8
   Plt
   170
   163
   132
   Cr
   0.9
   1.0
   1.0
   Glucose
   144
   122
   192
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:70/56, Alk Phos / T
   Bili:136/4.5, Amylase / Lipase:47/54, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:175 IU/L,
   Ca++:7.8 mg/dL, Mg++:1.5 mg/dL, PO4:3.2 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
    # GI BLEED: s/p ERCP and sphincterotomy.  The patient had continued
   episodes of [**Last Name (un) 1165**]/bloody stools.  Pt was transfused 3U pRBC due to
   progressively decreasing Hct. Today Hct is 30.8. ERCP aware.  The
   patient went to ERCP and was found to have clots and her stent had
   migrated into the duodenum.  She also had cautery and epi to stop
   additional bleeding.  Her post-ERCP Hct dropped to 21.1
   Hemodynamically the patient
s pressures have been 90-110
   post-procedure.
   - f/u ERCP recs
   - will transfuse 2U pRBC and 2U FFP
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  Pt returned to ERCP and
   the stent had migrated and addition stone was found.  Pt had new stent
   placed and the old one was recovered.  LFT are trending down, but TBili
   has increased to 4.5 No evidence of post-ERCP pancreatitis
   - check direct bili levels
   -continue antibiotics cipro / flagyl
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 3 yesterday and
   this AM, pt asymptomatic.   Home med is atenolol, but will use
   lopressor for shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Will cont home diovan
   - lopressor 12.5mg TID
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-1**] 12:01 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Transfused 1u PRBC during the day. ~400 cc with hct to 23.4,
   transfused 2u PRBC
   - Continued to have melanotic stools. 10p - large melanotic stool .  Pt
   also lost conciousness on the commode .
   - Per GI, clears today, NPO at midnight with possible endoscopy
   tomorrow
   - Switched to metoprolol tid for hypertension.  Hypertensive this AM up
   to 200s/50s, received labetolol 10 mg IV x2.
   - This AM continues to have melanotic stool now with coffee gound
   emesis
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ciprofloxacin - [**2107-10-31**] 07:45 PM
   Metronidazole - [**2107-11-1**] 12:11 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-10-31**] 07:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Cardiovascular: No(t) Chest pain, No(t) Palpitations
   Respiratory: No(t) Cough, No(t) Dyspnea
   Gastrointestinal: Abdominal pain, No(t) Nausea, No(t) Emesis, Diarrhea
   Neurologic: No(t) Headache
   Flowsheet Data as of  [**2107-11-1**] 07:23 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 74 (61 - 82) bpm
   BP: 202/67(96) {96/39(56) - 202/85(96)} mmHg
   RR: 19 (15 - 26) insp/min
   SpO2: 99%
   Heart rhythm: AV Paced
           Total In:
                                                                  1,784 mL
                                                                    622 mL
   PO:
                                                                    120 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    945 mL
                                                                    169 mL
   Blood products:
                                                                    719 mL
                                                                    403 mL
   Total out:
                                                                  1,200 mL
                                                                    190 mL
   Urine:
                                                                    450 mL
                                                                    180 mL
   NG:
   10 mL
   Stool:
                                                                    750 mL
   Drains:
   Balance:
                                                                    584 mL
                                                                    432 mL
   Respiratory support
   SpO2: 99%
   ABG: ///18/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal),  RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Bowel sounds present, No(t) Distended, Tender: lower
   abdomin
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   132 K/uL
   11.0 g/dL
   192 mg/dL
   1.0 mg/dL
   18 mEq/L
   4.0 mEq/L
   48 mg/dL
   112 mEq/L
   138 mEq/L
   30.8 %
   9.3 K/uL
        [image002.jpg]
                             [**2107-10-30**]  04:13 PM
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
                             [**2107-10-31**]  07:59 AM
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
   WBC
   16.1
   11.5
   9.3
   Hct
   32.2
   27.4
   26.7
   25.8
   27.7
   24.1
   23.4
   30.8
   Plt
   170
   163
   132
   Cr
   0.9
   1.0
   1.0
   Glucose
   144
   122
   192
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:70/56, Alk Phos / T
   Bili:136/4.5, Amylase / Lipase:47/54, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:175 IU/L,
   Ca++:7.8 mg/dL, Mg++:1.5 mg/dL, PO4:3.2 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
    # GI BLEED: s/p ERCP and sphincterotomy.  The patient had continued
   episodes of [**Last Name (un) 1165**]/bloody stools.  Pt was transfused 3U pRBC due to
   progressively decreasing Hct. Today Hct is 30.8. ERCP aware.  The
   patient went to ERCP and was found to have clots and her stent had
   migrated into the duodenum.  She also had cautery and epi to stop
   additional bleeding.  Her post-ERCP Hct dropped to 21.1
   Hemodynamically the patient
s pressures have been 90-110
   post-procedure.
   - f/u ERCP recs
   - will transfuse 2U pRBC and 2U FFP
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  Pt returned to ERCP and
   the stent had migrated and addition stone was found.  Pt had new stent
   placed and the old one was recovered.  LFT are trending down, but TBili
   has increased to 4.5 No evidence of post-ERCP pancreatitis
   - check direct bili levels
   -continue antibiotics cipro / flagyl
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 3 yesterday and
   this AM, pt asymptomatic.   Home med is atenolol, but will use
   lopressor for shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Will cont home diovan
   - lopressor 12.5mg TID
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-1**] 12:01 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following summary and potential medical complications are noted:

Summary:

The patient, an 87-year-old female, is admitted to the ICU with cholangitis, sphincterotomy bleeding, and stent migration. She has been transfused with 3 units of packed red blood cells (PRBC) and 2 units of fresh frozen plasma (FFP) due to progressively decreasing hemoglobin levels. The patient has also undergone ERCP and was found to have clots and her stent had migrated into the duodenum. She was given cautionary and epinephrine to stop additional bleeding.

Potential Medical Complications:

1. Bleeding: The patient has a high risk of bleeding due to the sphincterotomy and stent migration. Monitor hemoglobin levels and transfuse as necessary.
2. Cholangitis: The patient has cholangitis, which may worsen if not treated promptly. Continue antibiotics and monitor liver function tests (LFTs) and bilirubin levels.
3. Pancreatitis: The patient has a risk of pancreatitis due to the ERCP procedure. Monitor pancreatic enzymes and lipase levels.
4. Hepatitis: The patient has elevated transaminase levels, which may indicate hepatitis. Monitor LFTs and pancreatic enzymes.
5. Hypertension: The patient has hypertension and was given labetolol to control blood pressure. Monitor blood pressure and adjust medication as necessary.
6. Hyperlipidemia: The patient has hyperlipidemia, which may worsen with the use of statins. Monitor lipid levels and adjust medication as necessary.
7. Diabetes: The patient has diabetes and is at risk of hypoglycemia while NPO. Monitor blood glucose levels and adjust insulin as necessary.
8. Vitamin B12 deficiency: The patient has a vitamin B12 deficiency, which may worsen if not treated promptly. Monitor vitamin B12 levels and adjust treatment as necessary.
9. Cardiovascular disease: The patient has a history of cardiovascular disease and is at risk of cardiac complications. Monitor cardiac enzymes and adjust treatment as necessary.
10. DVT: The patient is at risk of developing deep vein thrombosis (DVT) due to the use of heparin. Monitor for signs of DVT and adjust treatment as necessary.

In conclusion, the patient is at risk of several medical complications, including bleeding, cholangitis, pancreatitis, hepatitis, hypertension, hyperlipidemia, diabetes, vitamin B12 deficiency, cardiovascular disease, and DVT. Close monitoring and prompt treatment are necessary to prevent these complications and ensure the patient's safety and well-being."
165668.0,294776,2107-11-02 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Cholangitis
   24 Hour Events:
   - ERCP - clot removed, stent replaced.
   - Transfused 2U pRBCs, 2U FFP
   - Post-procedure hct 21, at 2200 = 26.7 (post-transfusion)
   - ERCP recs - If continues to drop in morning, get heme involved to
   assess for bleeding diathesis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Metronidazole - [**2107-11-1**] 04:30 PM
   Ciprofloxacin - [**2107-11-1**] 08:45 PM
   Infusions:
   Insulin - Regular - 2 units/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-11-1**] 08:15 AM
   Hydralazine - [**2107-11-1**] 06:14 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Tachycardia
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis, pt
   reports some crampy abdominal pain relieved by BM, pt with bloody
   stools
   Neurologic: denied light-headness, dizziness
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-2**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 73 (60 - 85) bpm
   BP: 155/58(80) {101/27(51) - 188/64(88)} mmHg
   RR: 14 (12 - 24) insp/min
   SpO2: 98%
   Heart rhythm: AV Paced
             Total In:
                                                                  3,119 mL
                                                                     87 mL
   PO:
                                                                     50 mL
             TF:
   IVF:
                                                                  1,319 mL
                                                                     87 mL
   Blood products:
                                                                  1,750 mL
   Total out:
                                                                    598 mL
                                                                    380 mL
   Urine:
                                                                    588 mL
                                                                    380 mL
   NG:
                                                                     10 mL
   Stool:
   Drains:
   Balance:
                                                                  2,521 mL
                                                                   -293 mL
   Respiratory support
   SpO2: 98%
   ABG: ///20/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   25.5 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
                             [**2107-10-31**]  07:59 AM
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
   WBC
   11.5
   9.3
   9.6
   Hct
   27.4
   26.7
   25.8
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   Plt
   163
   132
   82
   Cr
   1.0
   1.0
   1.1
   1.0
   Glucose
   122
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
    # GI BLEED: s/p ERCP and sphincterotomy.  The patient had continued
   episodes of [**Last Name (un) 1165**]/bloody stools.  Pt was transfused 2U pRBC due to
   progressively decreasing Hct. Today Hct is 25.5 down from 26.7 last
   night. The patient went to ERCP and was found to have clots and her
   stent had migrated into the duodenum.  She also had cautery and epi to
   stop additional bleeding.  Hemodynamically the patient has been
   stable.  Likely continued bleeding from ERCP site.  Pt with
   thrombocytopenia this AM of 82.  Pt has not been on heparin due to GI
   bleed, but did recieve SQ heparin on admission.  INR and PTT wnl.
   Cipro and flagyl not associated with thrombocytopenia.
   - check HIT panel, check smear
   - Hem/ Onc to eval
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  Pt returned to ERCP and
   the stent had migrated and addition stone was found.  Pt had new stent
   placed and the old one was recovered.  LFT and Amylase are elevated
   today. TBili has minimally decreased to 4.2. Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: See above. HIT vs ITP vs Medications vs MDS
   - check HIT panel and smear
   - Hem/Onc consult
   -check CBC q6
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday and
   this AM, pt asymptomatic.   Home med is atenolol, but will use
   lopressor for shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Will cont home diovan
   - lopressor 12.5mg TID
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-1**] 12:01 AM
   16 Gauge - [**2107-11-1**] 03:16 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Cholangitis
   24 Hour Events:
   - ERCP - clot removed, stent replaced.
   - Transfused 2U pRBCs, 2U FFP
   - Post-procedure hct 21, at 2200 = 26.7 (post-transfusion)
   - ERCP recs - If continues to drop in morning, get heme involved to
   assess for bleeding diathesis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Metronidazole - [**2107-11-1**] 04:30 PM
   Ciprofloxacin - [**2107-11-1**] 08:45 PM
   Infusions:
   Insulin - Regular - 2 units/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-11-1**] 08:15 AM
   Hydralazine - [**2107-11-1**] 06:14 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Tachycardia
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis, pt
   reports some crampy abdominal pain relieved by BM, pt with bloody
   stools
   Neurologic: denied light-headness, dizziness
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-2**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 73 (60 - 85) bpm
   BP: 155/58(80) {101/27(51) - 188/64(88)} mmHg
   RR: 14 (12 - 24) insp/min
   SpO2: 98%
   Heart rhythm: AV Paced
             Total In:
                                                                  3,119 mL
                                                                     87 mL
   PO:
                                                                     50 mL
             TF:
   IVF:
                                                                  1,319 mL
                                                                     87 mL
   Blood products:
                                                                  1,750 mL
   Total out:
                                                                    598 mL
                                                                    380 mL
   Urine:
                                                                    588 mL
                                                                    380 mL
   NG:
                                                                     10 mL
   Stool:
   Drains:
   Balance:
                                                                  2,521 mL
                                                                   -293 mL
   Respiratory support
   SpO2: 98%
   ABG: ///20/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   25.5 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
                             [**2107-10-31**]  07:59 AM
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
   WBC
   11.5
   9.3
   9.6
   Hct
   27.4
   26.7
   25.8
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   Plt
   163
   132
   82
   Cr
   1.0
   1.0
   1.1
   1.0
   Glucose
   122
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
    # GI BLEED: s/p ERCP and sphincterotomy.  The patient had continued
   episodes of [**Last Name (un) 1165**]/bloody stools.  Pt was transfused 2U pRBC due to
   progressively decreasing Hct. Today Hct is 25.5 down from 26.7 last
   night. The patient went to ERCP and was found to have clots and her
   stent had migrated into the duodenum.  She also had cautery and epi to
   stop additional bleeding.  Hemodynamically the patient has been
   stable.  Likely continued bleeding from ERCP site.  Pt with
   thrombocytopenia this AM of 82.  Pt has not been on heparin due to GI
   bleed, but did recieve SQ heparin on admission.  INR and PTT wnl.
   Cipro and flagyl not associated with thrombocytopenia.
   - check HIT panel, check smear
   - Hem/ Onc to eval
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  Pt returned to ERCP and
   the stent had migrated and addition stone was found.  Pt had new stent
   placed and the old one was recovered.  LFT and Amylase are elevated
   today. TBili has minimally decreased to 4.2. Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: See above. HIT vs ITP vs Medications vs MDS
   - check HIT panel and smear
   - Hem/Onc consult
   -check CBC q6
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday and
   this AM, pt asymptomatic.   Home med is atenolol, but will use
   lopressor for shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Will cont home diovan
   - lopressor 12.5mg TID
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-1**] 12:01 AM
   16 Gauge - [**2107-11-1**] 03:16 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications can arise:

1. Continued bleeding from the ERCP site: The patient's hemoglobin level has decreased from 26.7 to 25.5, and the platelet count is 82. The patient has not been on heparin due to the risk of bleeding, but received SQ heparin on admission. A HIT panel and smear should be checked, and hematology consultation should be considered.
2. Post-ERCP pancreatitis: The patient's amylase level is elevated, and the bilirubin level has minimally decreased to 4.2. The patient is at risk for post-ERCP pancreatitis, and should be monitored closely for signs of pancreatitis.
3. Thrombocytopenia: The patient's platelet count is 82, which is below normal. The cause of thrombocytopenia is unclear, and a HIT panel and smear should be checked. Hematology consultation should be considered to rule out other causes such as ITP, medications, or MDS.
4. Transaminase elevation: The patient's LFT and bilirubin levels are trending down, but the cause of the initial elevation is unclear. Further evaluation with hepatitis serologies and trend of LFTs and pancreatic enzymes is necessary.
5. Hypertension: The patient's blood pressure is elevated, and the patient is at risk for bleeding. The patient is currently taking lopressor 12.5mg TID, but the home medication is atenolol.
6. Hyperlipidemia: The patient's lipase level is elevated, and the patient is at risk for pancreatitis. The patient should be monitored closely for signs of pancreatitis, and the medication lipitor should be held.
7. B12 deficiency: The patient's B12 level is normal, but the patient is at risk for deficiency due to malnutrition and malabsorption. The patient should be monitored closely for signs of deficiency.
8. DMII: The patient's blood glucose level is elevated, and the patient is at risk for complications of diabetes. The patient should be monitored closely for signs of hyperglycemia, and the medication metformin should be held.
9. FEN: The patient's electrolyte levels are abnormal, and the patient is at risk for electrolyte imbalances. The patient should be monitored closely for signs of electrolyte imbalances, and the medication PPI should be continued.
10. Access: The patient has multiple IV lines, which increases the risk of complications such as infection and bleeding. The patient should be monitored closely for signs of infection and bleeding.

Based on the patient's condition, the following plan should be implemented:

1. Continue antibiotics for cholangitis.
2. Monitor the patient's hemoglobin level and platelet count closely.
3. Check the patient's LFT and pancreatic enzymes daily.
4. Monitor the patient's blood pressure and electrolyte levels closely.
5. Continue the patient's medications, including PPI and lopressor.
6. Monitor the patient's nutrition and hydration status closely.
7. Consider hematology consultation to rule out other causes of thrombocytopenia.
8. Monitor the patient's blood glucose level closely and consider adjusting the patient's medication regimen as necessary.
9. Consider consulting with a gastroenterologist to further evaluate the patient's condition and develop a plan for management."
165668.0,294776,2107-11-02 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Cholangitis
   24 Hour Events:
   - ERCP - clot removed, stent replaced.
   - Transfused 2U pRBCs, 2U FFP
   - Post-procedure hct 21, at 2200 = 26.7 (post-transfusion)
   - Post-procedure became hypotensive and hypothermic, pt responded to
   fluids and blood.  started on vanc.
   - ERCP recs - If continues to drop in morning, get heme involved to
   assess for bleeding diathesis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Metronidazole - [**2107-11-1**] 04:30 PM
   Ciprofloxacin - [**2107-11-1**] 08:45 PM
   Infusions:
   Insulin - Regular - 2 units/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-11-1**] 08:15 AM
   Hydralazine - [**2107-11-1**] 06:14 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Tachycardia
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis, pt
   reports some crampy abdominal pain relieved by BM, pt with bloody
   stools
   Neurologic: denied light-headness, dizziness
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-2**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 73 (60 - 85) bpm
   BP: 155/58(80) {101/27(51) - 188/64(88)} mmHg
   RR: 14 (12 - 24) insp/min
   SpO2: 98%
   Heart rhythm: AV Paced
             Total In:
                                                                  3,119 mL
                                                                     87 mL
   PO:
                                                                     50 mL
             TF:
   IVF:
                                                                  1,319 mL
                                                                     87 mL
   Blood products:
                                                                  1,750 mL
   Total out:
                                                                    598 mL
                                                                    380 mL
   Urine:
                                                                    588 mL
                                                                    380 mL
   NG:
                                                                     10 mL
   Stool:
   Drains:
   Balance:
                                                                  2,521 mL
                                                                   -293 mL
   Respiratory support
   SpO2: 98%
   ABG: ///20/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   25.5 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
                             [**2107-10-31**]  07:59 AM
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
   WBC
   11.5
   9.3
   9.6
   Hct
   27.4
   26.7
   25.8
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   Plt
   163
   132
   82
   Cr
   1.0
   1.0
   1.1
   1.0
   Glucose
   122
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
    # GI BLEED: s/p ERCP and sphincterotomy.  The patient had continued
   episodes of [**Last Name (un) 1165**]/bloody stools.  Pt was transfused 2U pRBC due to
   progressively decreasing Hct. Today Hct is 25.5 down from 26.7 last
   night. The patient went to ERCP and was found to have clots and her
   stent had migrated into the duodenum.  She also had cautery and epi to
   stop additional bleeding.  Hemodynamically the patient has been
   stable.  Likely continued bleeding from ERCP site. Pt platelets
   decreased likely [**2-26**] to transfusions.  INR and PTT wnl.  Cipro and
   flagyl not associated with thrombocytopenia, however pt given Vanco
   that could be myelosupressive.  ERCP plans to take her back to the OR
   today.
   - will transfuse 1U pRBC per ERCP
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  Pt returned to ERCP and
   the stent had migrated and addition stone was found.  Pt had new stent
   placed and the old one was recovered.  Pt was hypotensive and
   hypothermic.  Pt started on Vanco post procedure.  LFT and Amylase are
   elevated today. TBili has minimally decreased to 4.2. Pt at risk for
   post-ERCP pancreatitis.
   -continue antibiotics cipro / flagyl
   - will switch vanco to amp
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: See above.  Likely [**2-26**] multiple transfusions.
   Unlikely HIT given not thrombotic and hasn
t received heparin.
   Possible contribution from vanco.
   -check CBC q6
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday and
   this AM, pt asymptomatic.   Home med is atenolol, but will use
   lopressor for shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Will start captopril since short acting ACE and normal renal fxn.
   - lopressor 12.5mg TID
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-1**] 12:01 AM
   16 Gauge - [**2107-11-1**] 03:16 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Cholangitis
   24 Hour Events:
   - ERCP - clot removed, stent replaced.
   - Transfused 2U pRBCs, 2U FFP
   - Post-procedure hct 21, at 2200 = 26.7 (post-transfusion)
   - Post-procedure became hypotensive and hypothermic, pt responded to
   fluids and blood.  started on vanc.
   - ERCP recs - If continues to drop in morning, get heme involved to
   assess for bleeding diathesis.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Metronidazole - [**2107-11-1**] 04:30 PM
   Ciprofloxacin - [**2107-11-1**] 08:45 PM
   Infusions:
   Insulin - Regular - 2 units/hour
   Other ICU medications:
   Pantoprazole (Protonix) - [**2107-11-1**] 08:15 AM
   Hydralazine - [**2107-11-1**] 06:14 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Tachycardia
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis, pt
   reports some crampy abdominal pain relieved by BM, pt with bloody
   stools
   Neurologic: denied light-headness, dizziness
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-2**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 73 (60 - 85) bpm
   BP: 155/58(80) {101/27(51) - 188/64(88)} mmHg
   RR: 14 (12 - 24) insp/min
   SpO2: 98%
   Heart rhythm: AV Paced
             Total In:
                                                                  3,119 mL
                                                                     87 mL
   PO:
                                                                     50 mL
             TF:
   IVF:
                                                                  1,319 mL
                                                                     87 mL
   Blood products:
                                                                  1,750 mL
   Total out:
                                                                    598 mL
                                                                    380 mL
   Urine:
                                                                    588 mL
                                                                    380 mL
   NG:
                                                                     10 mL
   Stool:
   Drains:
   Balance:
                                                                  2,521 mL
                                                                   -293 mL
   Respiratory support
   SpO2: 98%
   ABG: ///20/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Verbal stimuli, Oriented (to): x3,
   Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   25.5 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-30**]  09:33 PM
                             [**2107-10-31**]  01:40 AM
                             [**2107-10-31**]  07:59 AM
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
   WBC
   11.5
   9.3
   9.6
   Hct
   27.4
   26.7
   25.8
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   Plt
   163
   132
   82
   Cr
   1.0
   1.0
   1.1
   1.0
   Glucose
   122
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
    # GI BLEED: s/p ERCP and sphincterotomy.  The patient had continued
   episodes of [**Last Name (un) 1165**]/bloody stools.  Pt was transfused 2U pRBC due to
   progressively decreasing Hct. Today Hct is 25.5 down from 26.7 last
   night. The patient went to ERCP and was found to have clots and her
   stent had migrated into the duodenum.  She also had cautery and epi to
   stop additional bleeding.  Hemodynamically the patient has been
   stable.  Likely continued bleeding from ERCP site. Pt platelets
   decreased likely [**2-26**] to transfusions.  INR and PTT wnl.  Cipro and
   flagyl not associated with thrombocytopenia, however pt given Vanco
   that could be myelosupressive.  ERCP plans to take her back to the OR
   today.
   - will transfuse 1U pRBC per ERCP
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  Pt returned to ERCP and
   the stent had migrated and addition stone was found.  Pt had new stent
   placed and the old one was recovered.  Pt was hypotensive and
   hypothermic.  Pt started on Vanco post procedure.  LFT and Amylase are
   elevated today. TBili has minimally decreased to 4.2. Pt at risk for
   post-ERCP pancreatitis.
   -continue antibiotics cipro / flagyl
   - will switch vanco to amp
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT and Bilirubins
   are trending down.
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: See above.  Likely [**2-26**] multiple transfusions.
   Unlikely HIT given not thrombotic and hasn
t received heparin.
   Possible contribution from vanco.
   -check CBC q6
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday and
   this AM, pt asymptomatic.   Home med is atenolol, but will use
   lopressor for shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Will start captopril since short acting ACE and normal renal fxn.
   - lopressor 12.5mg TID
   .
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-1**] 12:01 AM
   16 Gauge - [**2107-11-1**] 03:16 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the patient's condition and potential medical complications:

**Summary:**

The patient is an 87-year-old female admitted to the ICU with cholangitis, post-ERCP sphincterotomy and stent placement. She has a history of sphincterotomy bleeding, which was locally controlled, and has been transfused 2U pRBCs due to progressively decreasing Hct. The patient has continued episodes of bloody stools and has been diagnosed with thrombocytopenia, likely due to multiple transfusions. She has also been started on vancomycin, which may be contributing to her thrombocytopenia.

**Potential Medical Complications:**

1. **Bleeding:** The patient has a high risk of bleeding due to her history of sphincterotomy bleeding and thrombocytopenia. She has been transfused 2U pRBCs and has a decreasing Hct, indicating ongoing bleeding.
2. **Cholangitis:** The patient has cholangitis, which can lead to sepsis and organ failure if not treated promptly and effectively.
3. **Thrombocytopenia:** The patient's thrombocytopenia may be due to multiple transfusions, vancomycin, or other factors. This increases her risk of bleeding and other complications.
4. **Pancreatitis:** The patient has a history of ERCP and stent placement, which increases her risk of post-ERCP pancreatitis.
5. **Hepatic Encephalopathy:** The patient's liver function tests (LFTs) are elevated, which may indicate liver dysfunction and increase her risk of hepatic encephalopathy.
6. **Infection:** The patient is at risk of developing infections, particularly sepsis, due to her cholangitis and thrombocytopenia.
7. **Gastrointestinal Bleeding:** The patient has a history of gastrointestinal bleeding and may continue to experience bleeding due to her thrombocytopenia and sphincterotomy bleeding.

**Recommendations:**

1. Monitor the patient's bleeding closely and transfuse 1U pRBCs as needed.
2. Continue antibiotics and antifungal therapy to treat cholangitis and prevent sepsis.
3. Monitor the patient's platelet count and transfuse platelets as needed.
4. Monitor the patient's liver function tests and pancreatic enzymes to assess for liver and pancreatic dysfunction.
5. Monitor the patient's electrolyte levels and adjust therapy as needed.
6. Consider consulting a gastroenterologist or hepatologist for further management of the patient's cholangitis and liver dysfunction.
7. Consider consulting a hematology specialist for further management of the patient's thrombocytopenia."
165668.0,294776,2107-11-03 06:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Cholangitis and GI bleed
   24 Hour Events:
   - Pt taken back to ERCP, no active bleeding found, but
   electrocauterization was performed in the erythematous area
   - Pt had large melanotic stool (200cc) at midnight, pt given 1U pRBC
   (midnight Hct was 28.4), had smaller melanotic BM early this morning
   - Informed ERCP fellow and told to cont to trend crit and transfuse as
   ness
   - Pt refusing labs, meds, and additional interventions. Pt has ""made
   peace.""  Attempted to call patient's son this AM, but no answer.
 ERCP - At [**2107-11-2**] 04:30 PM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-3**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t)
   Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria
   Psychiatric / Sleep: depressed
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-3**] 06:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.9
C (98.4
   HR: 76 (61 - 76) bpm
   BP: 199/74(106) {126/43(75) - 212/135(143)} mmHg
   RR: 20 (12 - 22) insp/min
   SpO2: 95%
   Heart rhythm: AV Paced
   Height: 63 Inch
           Total In:
                                                                  1,121 mL
                                                                    441 mL
   PO:
           TF:
   IVF:
                                                                    746 mL
                                                                    165 mL
   Blood products:
                                                                    375 mL
                                                                    276 mL
   Total out:
                                                                  1,305 mL
                                                                    140 mL
   Urine:
                                                                  1,305 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -184 mL
                                                                    301 mL
   Respiratory support
   SpO2: 95%
   ABG: ////
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Crackles :
   bibasilar)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x3,
   Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   28.4 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
   WBC
   9.3
   9.6
   Hct
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   Plt
   132
   82
   Cr
   1.0
   1.1
   1.0
   Glucose
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   #Code Status: Pt is DNR/DNI.  This morning patient is refusing all
   meds, labs, procedures.  The patient states she is ""at peace"" and
   doesn
t want further treatment.  Will talk with son this AM.
   - will discuss with son regarding patient's refusal for care, pt
   requested we speak with him.
   - further workup and eval pending patient
s decision to stop care.
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has
   continued episodes of melanotic stool, but this most likely represents
   previous bleed moving thru the bowel and not current bleeding.  Pt was
   transfused 1U pRBC due to progressively decreasing Hct. Hemodynamically
   the patient has been stable.  Likely continued bleeding from ERCP site.
   INR and PTT wnl.  However, the patient is currently refusing all meds,
   lab work and proceudres.
   - will discuss IR embolization if patient continues to bleed and
   require transfusions.
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.   Pt started on Vanco post
   procedure yesterday due to hypotension and hypothermia post proceudre.
   Was switched to Amp yesterday.  LFT and Amylase not drawn today. Pt at
   risk for post-ERCP pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  Pt refused labs this
   AM
   Negative hepatitis serology.
   - will attempt to trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   -Pt currently refusing blood draws.
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday ,pt
   asymptomatic.   Home med is atenolol, but will use lopressor for
   shorting acting [**Doctor Last Name 23**] given risk of bleed.   Pt does not want BP
   medications.
   -Cont captopril and will increase lopressor 25mg TID..
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:  ISS
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-2**] 10:09 AM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Cholangitis and GI bleed
   24 Hour Events:
   - Pt taken back to ERCP, no active bleeding found, but
   electrocauterization was performed in the erythematous area
   - Pt had large melanotic stool (200cc) at midnight, pt given 1U pRBC
   (midnight Hct was 28.4), had smaller melanotic BM early this morning
   - Informed ERCP fellow and told to cont to trend crit and transfuse as
   ness
   - Pt refusing labs, meds, and additional interventions. Pt has ""made
   peace.""  Attempted to call patient's son this AM, but no answer.
 ERCP - At [**2107-11-2**] 04:30 PM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-3**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t)
   Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria
   Psychiatric / Sleep: depressed
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-3**] 06:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.9
C (98.4
   HR: 76 (61 - 76) bpm
   BP: 199/74(106) {126/43(75) - 212/135(143)} mmHg
   RR: 20 (12 - 22) insp/min
   SpO2: 95%
   Heart rhythm: AV Paced
   Height: 63 Inch
           Total In:
                                                                  1,121 mL
                                                                    441 mL
   PO:
           TF:
   IVF:
                                                                    746 mL
                                                                    165 mL
   Blood products:
                                                                    375 mL
                                                                    276 mL
   Total out:
                                                                  1,305 mL
                                                                    140 mL
   Urine:
                                                                  1,305 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -184 mL
                                                                    301 mL
   Respiratory support
   SpO2: 95%
   ABG: ////
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Crackles :
   bibasilar)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x3,
   Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   28.4 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
   WBC
   9.3
   9.6
   Hct
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   Plt
   132
   82
   Cr
   1.0
   1.1
   1.0
   Glucose
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   #Code Status: Pt is DNR/DNI.  This morning patient is refusing all
   meds, labs, procedures.  The patient states she is ""at peace"" and
   doesn
t want further treatment.  Will talk with son this AM.
   - will discuss with son regarding patient's refusal for care, pt
   requested we speak with him.
   - further workup and eval pending patient
s decision to stop care.
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has
   continued episodes of melanotic stool, but this most likely represents
   previous bleed moving thru the bowel and not current bleeding.  Pt was
   transfused 1U pRBC due to progressively decreasing Hct. Hemodynamically
   the patient has been stable.  Likely continued bleeding from ERCP site.
   INR and PTT wnl.  However, the patient is currently refusing all meds,
   lab work and proceudres.
   - will discuss IR embolization if patient continues to bleed and
   require transfusions.
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.   Pt started on Vanco post
   procedure yesterday due to hypotension and hypothermia post proceudre.
   Was switched to Amp yesterday.  LFT and Amylase not drawn today. Pt at
   risk for post-ERCP pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  Pt refused labs this
   AM
   Negative hepatitis serology.
   - will attempt to trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   -Pt currently refusing blood draws.
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday ,pt
   asymptomatic.   Home med is atenolol, but will use lopressor for
   shorting acting [**Doctor Last Name 23**] given risk of bleed.   Pt does not want BP
   medications.
   -Cont captopril and will increase lopressor 25mg TID..
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:  ISS
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-2**] 10:09 AM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following potential medical complications can arise:

1. Continued bleeding from the ERCP site: The patient has had two episodes of melanotic stool, which may indicate continued bleeding from the ERCP site. The patient's hemoglobin level is decreasing, and they are refusing transfusions, which increases the risk of bleeding.
2. Cholangitis: The patient has cholangitis, which is an infection of the bile ducts. The patient's bilirubin levels are elevated, and they have a history of stones in the common bile duct. The patient's infection is not adequately treated, which increases the risk of sepsis and organ failure.
3. Pancreatitis: The patient has a history of pancreatitis, and the ERCP procedure may have exacerbated the condition. The patient's amylase levels are elevated, and they are at risk for further pancreatitis.
4. Thrombocytopenia: The patient has a low platelet count, which may be due to dilutional thrombocytopenia from multiple transfusions, consumption from bleeding, or a possible contribution from vancomycin.
5. Hypertension: The patient has hypertension, and their blood pressure is not well-controlled. The patient is refusing antihypertensive medications, which increases the risk of hypertensive crisis.
6. Electrolyte imbalance: The patient has a history of electrolyte imbalances, including hyperkalemia, hypokalemia, and hypomagnesemia. The patient's electrolyte levels should be closely monitored to prevent further imbalance.
7. Infection: The patient has a history of infections, including cholangitis and pancreatitis. The patient's infection is not adequately treated, which increases the risk of sepsis and organ failure.
8. Organ failure: The patient's condition is unstable, and they are at risk for organ failure, including respiratory, cardiac, and renal failure.

To mitigate these potential complications, the patient should receive:

1. Aggressive treatment for bleeding, including transfusions and embolization.
2. Adequate treatment for cholangitis, including antibiotics and drainage of the bile ducts.
3. Treatment for pancreatitis, including analgesics and supportive care.
4. Management of thrombocytopenia, including platelet transfusions and cessation of vancomycin.
5. Control of hypertension, including antihypertensive medications and close monitoring.
6. Electrolyte management, including close monitoring and correction of imbalances.
7. Infection control measures, including antibiotics and drainage of the bile ducts.
8. Close monitoring of the patient's condition, including frequent assessments of vital signs, laboratory results, and imaging studies."
165668.0,294776,2107-11-03 06:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Cholangitis and GI bleed
   24 Hour Events:
   - Pt taken back to ERCP, no active bleeding found, but
   electrocauterization was performed in the erythematous area
   - Pt had large melanotic stool (200cc) at midnight, pt given 1U pRBC
   (midnight Hct was 28.4), had smaller melanotic BM early this morning
   - Informed ERCP fellow and told to cont to trend crit and transfuse as
   ness
   - Pt refusing labs, meds, and additional interventions. Pt has ""made
   peace.""  Attempted to call patient's son this AM, but no answer.
 ERCP - At [**2107-11-2**] 04:30 PM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-3**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t)
   Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria
   Psychiatric / Sleep: depressed
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-3**] 06:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.9
C (98.4
   HR: 76 (61 - 76) bpm
   BP: 199/74(106) {126/43(75) - 212/135(143)} mmHg
   RR: 20 (12 - 22) insp/min
   SpO2: 95%
   Heart rhythm: AV Paced
   Height: 63 Inch
           Total In:
                                                                  1,121 mL
                                                                    441 mL
   PO:
           TF:
   IVF:
                                                                    746 mL
                                                                    165 mL
   Blood products:
                                                                    375 mL
                                                                    276 mL
   Total out:
                                                                  1,305 mL
                                                                    140 mL
   Urine:
                                                                  1,305 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -184 mL
                                                                    301 mL
   Respiratory support
   SpO2: 95%
   ABG: ////
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Crackles :
   bibasilar)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x3,
   Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   28.4 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
   WBC
   9.3
   9.6
   Hct
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   Plt
   132
   82
   Cr
   1.0
   1.1
   1.0
   Glucose
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   #Code Status: Pt is DNR/DNI.  This morning patient is refusing all
   meds, labs, procedures.  The patient states she is ""at peace""
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has
   continued episodes of melanotic stool.  Pt was transfused 1U pRBC due
   to progressively decreasing Hct. Hemodynamically the patient has been
   stable.  Likely continued bleeding from ERCP site. INR and PTT wnl.
   However, the patient is currently refusing all meds, lab work and
   proceudres.
   - will discuss with son regarding patient's refusal for care, pt
   requested we speak with him.
   - will discuss IR embolization if patient continues to bleed and
   require transfusions.
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.   Pt started on Vanco post
   procedure yesterday due to hypotension and hypothermia post proceudre.
   Was switched to Amp yesterday.  LFT and Amylase are elevated today.
   TBili has minimally decreased to 4.2. Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT are
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.   Unlikely HIT given not thrombotic and
   hasn
t received heparin.  Possible contribution from vanco.
   -check CBC q6
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday ,pt
   asymptomatic.   Home med is atenolol, but will use lopressor for
   shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Cont captopril and will increase lopressor 25mg TID..
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-2**] 10:09 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Cholangitis and GI bleed
   24 Hour Events:
   - Pt taken back to ERCP, no active bleeding found, but
   electrocauterization was performed in the erythematous area
   - Pt had large melanotic stool (200cc) at midnight, pt given 1U pRBC
   (midnight Hct was 28.4), had smaller melanotic BM early this morning
   - Informed ERCP fellow and told to cont to trend crit and transfuse as
   ness
   - Pt refusing labs, meds, and additional interventions. Pt has ""made
   peace.""  Attempted to call patient's son this AM, but no answer.
 ERCP - At [**2107-11-2**] 04:30 PM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-3**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t)
   Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria
   Psychiatric / Sleep: depressed
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-3**] 06:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.9
C (98.4
   HR: 76 (61 - 76) bpm
   BP: 199/74(106) {126/43(75) - 212/135(143)} mmHg
   RR: 20 (12 - 22) insp/min
   SpO2: 95%
   Heart rhythm: AV Paced
   Height: 63 Inch
           Total In:
                                                                  1,121 mL
                                                                    441 mL
   PO:
           TF:
   IVF:
                                                                    746 mL
                                                                    165 mL
   Blood products:
                                                                    375 mL
                                                                    276 mL
   Total out:
                                                                  1,305 mL
                                                                    140 mL
   Urine:
                                                                  1,305 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -184 mL
                                                                    301 mL
   Respiratory support
   SpO2: 95%
   ABG: ////
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Crackles :
   bibasilar)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x3,
   Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   28.4 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
   WBC
   9.3
   9.6
   Hct
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   Plt
   132
   82
   Cr
   1.0
   1.1
   1.0
   Glucose
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   #Code Status: Pt is DNR/DNI.  This morning patient is refusing all
   meds, labs, procedures.  The patient states she is ""at peace""
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has
   continued episodes of melanotic stool.  Pt was transfused 1U pRBC due
   to progressively decreasing Hct. Hemodynamically the patient has been
   stable.  Likely continued bleeding from ERCP site. INR and PTT wnl.
   However, the patient is currently refusing all meds, lab work and
   proceudres.
   - will discuss with son regarding patient's refusal for care, pt
   requested we speak with him.
   - will discuss IR embolization if patient continues to bleed and
   require transfusions.
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.   Pt started on Vanco post
   procedure yesterday due to hypotension and hypothermia post proceudre.
   Was switched to Amp yesterday.  LFT and Amylase are elevated today.
   TBili has minimally decreased to 4.2. Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  LFT are
   - f/u hepatitis serologies
   - will trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.   Unlikely HIT given not thrombotic and
   hasn
t received heparin.  Possible contribution from vanco.
   -check CBC q6
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday ,pt
   asymptomatic.   Home med is atenolol, but will use lopressor for
   shorting acting [**Doctor Last Name 23**] given risk of bleed.
   -Cont captopril and will increase lopressor 25mg TID..
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  Sips for now, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-2**] 10:09 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 87-year-old female with cholangitis and gastrointestinal bleeding. She has undergone ERCP with sphincterotomy and stent placement, but continues to experience bleeding episodes, requiring transfusions and electrocauterization. The patient is currently refusing all medications, labs, and procedures, stating she is ""at peace.""

The patient's vital signs are stable, with a temperature of 36.9C, heart rate of 76 beats per minute, and blood pressure of 199/74 mmHg. Her respiratory rate is 20 breaths per minute, and her oxygen saturation is 95% on room air.

The patient's laboratory results show:

* Hemoglobin: 9.5 g/dL
* Hematocrit: 28.4%
* Platelet count: 132
* White blood cell count: 9.3 x 10^9/L
* Blood urea nitrogen: 20 mg/dL
* Creatinine: 1.0 mg/dL
* Glucose: 192 mg/dL
* Electrolytes: within normal range

The patient's physical examination is notable for:

* General appearance: no acute distress, thin
* Cardiovascular: normal S1 and S2 heart sounds, regular rhythm
* Respiratory: symmetric expansion, bibasilar crackles
* Abdominal: soft, non-tender, bowel sounds present
* Neurologic: attentive, responds to verbal commands, oriented to person, place, and time

The patient's medical conditions include:

* Cholangitis: s/p ERCP with sphincterotomy and stent placement for cholangitis, stones in the common bile duct
* Gastrointestinal bleeding: s/p ERCP and sphincterotomy, with ongoing episodes of melanotic stool
* Thrombocytopenia: likely due to dilutional effect from multiple transfusions and consumption from bleeding
* Transaminase elevation: likely due to cholangitis
* Hypertension: controlled with medication
* Coronary artery disease: no active issues
* B12 deficiency: treated with supplementation
* Hyperlipidemia: treated with medication hold
* Diabetes mellitus type II: treated with medication hold
* FEN (fatty liver disease): treated with medication hold

The patient's plan includes:

* Continue antibiotics and monitor for signs of infection
* Trend hemoglobin and hematocrit levels every 6 hours and transfuse as necessary
* Maintain active type and screen for bleeding
* Monitor for signs of pancreatitis and adjust treatment as necessary
* Continue to monitor and manage the patient's blood pressure and electrolyte levels
* Discuss the patient's refusal of care with her son and consider IR embolization if bleeding continues

Potential medical complications that can arise include:

* Continued bleeding from the ERCP site, leading to hypovolemic shock
* Pancreatitis, which can lead to organ failure
* Infection, which can lead to sepsis and organ failure
* Thrombocytopenia, which can increase the risk of bleeding
* Transaminase elevation, which can indicate liver damage
* Hypertension, which can increase the risk of cardiovascular complications
* Coronary artery disease, which can increase the risk of myocardial infarction
* B12 deficiency, which can lead to neurological symptoms
* Hyperlipidemia, which can increase the risk of cardiovascular complications
* Diabetes mellitus type II, which can increase the risk of complications such as ketoacidosis and hyperosmolar nonketotic coma."
165668.0,294776,2107-11-03 06:52:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Cholangitis and GI bleed
   24 Hour Events:
   - Pt taken back to ERCP, no active bleeding found, but
   electrocauterization was performed in the erythematous area
   - Pt had large melanotic stool (200cc) at midnight, pt given 1U pRBC
   (midnight Hct was 28.4), had smaller melanotic BM early this morning
   - Informed ERCP fellow and told to cont to trend crit and transfuse as
   ness
   - Pt refusing labs, meds, and additional interventions. Pt has ""made
   peace.""  Attempted to call patient's son this AM, but no answer.
 ERCP - At [**2107-11-2**] 04:30 PM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-3**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t)
   Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria
   Psychiatric / Sleep: depressed
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-3**] 06:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.9
C (98.4
   HR: 76 (61 - 76) bpm
   BP: 199/74(106) {126/43(75) - 212/135(143)} mmHg
   RR: 20 (12 - 22) insp/min
   SpO2: 95%
   Heart rhythm: AV Paced
   Height: 63 Inch
           Total In:
                                                                  1,121 mL
                                                                    441 mL
   PO:
           TF:
   IVF:
                                                                    746 mL
                                                                    165 mL
   Blood products:
                                                                    375 mL
                                                                    276 mL
   Total out:
                                                                  1,305 mL
                                                                    140 mL
   Urine:
                                                                  1,305 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -184 mL
                                                                    301 mL
   Respiratory support
   SpO2: 95%
   ABG: ////
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Crackles :
   bibasilar)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x3,
   Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   28.4 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
   WBC
   9.3
   9.6
   Hct
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   Plt
   132
   82
   Cr
   1.0
   1.1
   1.0
   Glucose
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   #Code Status: Pt is DNR/DNI.  This morning patient is refusing all
   meds, labs, procedures.  The patient states she is ""at peace"" and
   doesn
t want further treatment.  Will talk with son this AM.
   - will discuss with son regarding patient's refusal for care, pt
   requested we speak with him.
   - further workup and eval pending patient
s decision to stop care.
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has
   continued episodes of melanotic stool.  Pt was transfused 1U pRBC due
   to progressively decreasing Hct. Hemodynamically the patient has been
   stable.  Likely continued bleeding from ERCP site. INR and PTT wnl.
   However, the patient is currently refusing all meds, lab work and
   proceudres.
   - will discuss IR embolization if patient continues to bleed and
   require transfusions.
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.   Pt started on Vanco post
   procedure yesterday due to hypotension and hypothermia post proceudre.
   Was switched to Amp yesterday.  LFT and Amylase not drawn today. Pt at
   risk for post-ERCP pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  Pt refused labs this
   AM
   Negative hepatitis serology.
   - will attempt to trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   -Pt currently refusing blood draws.
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday ,pt
   asymptomatic.   Home med is atenolol, but will use lopressor for
   shorting acting [**Doctor Last Name 23**] given risk of bleed.   Pt does not want BP
   medications.
   -Cont captopril and will increase lopressor 25mg TID..
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:  ISS
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-2**] 10:09 AM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Cholangitis and GI bleed
   24 Hour Events:
   - Pt taken back to ERCP, no active bleeding found, but
   electrocauterization was performed in the erythematous area
   - Pt had large melanotic stool (200cc) at midnight, pt given 1U pRBC
   (midnight Hct was 28.4), had smaller melanotic BM early this morning
   - Informed ERCP fellow and told to cont to trend crit and transfuse as
   ness
   - Pt refusing labs, meds, and additional interventions. Pt has ""made
   peace.""  Attempted to call patient's son this AM, but no answer.
 ERCP - At [**2107-11-2**] 04:30 PM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-3**] 12:00 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever
   Ear, Nose, Throat: Dry mouth
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t)
   Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria
   Psychiatric / Sleep: depressed
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2107-11-3**] 06:51 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.9
C (98.4
   HR: 76 (61 - 76) bpm
   BP: 199/74(106) {126/43(75) - 212/135(143)} mmHg
   RR: 20 (12 - 22) insp/min
   SpO2: 95%
   Heart rhythm: AV Paced
   Height: 63 Inch
           Total In:
                                                                  1,121 mL
                                                                    441 mL
   PO:
           TF:
   IVF:
                                                                    746 mL
                                                                    165 mL
   Blood products:
                                                                    375 mL
                                                                    276 mL
   Total out:
                                                                  1,305 mL
                                                                    140 mL
   Urine:
                                                                  1,305 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -184 mL
                                                                    301 mL
   Respiratory support
   SpO2: 95%
   ABG: ////
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), RRR
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Diminished), (Left DP pulse: Diminished)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Crackles :
   bibasilar)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Trace, Left: Trace
   Skin:  Not assessed
   Neurologic: Attentive, Responds to: Not assessed, Oriented (to): x3,
   Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   82 K/uL
   9.5 g/dL
   80 mg/dL
   1.0 mg/dL
   20 mEq/L
   3.6 mEq/L
   40 mg/dL
   110 mEq/L
   140 mEq/L
   28.4 %
   9.6 K/uL
        [image002.jpg]
                             [**2107-10-31**]  03:15 PM
                             [**2107-10-31**]  07:25 PM
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
   WBC
   9.3
   9.6
   Hct
   27.7
   24.1
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   Plt
   132
   82
   Cr
   1.0
   1.1
   1.0
   Glucose
   192
   393
   80
   Other labs: PT / PTT / INR:13.4/25.1/1.1, ALT / AST:242/372, Alk Phos /
   T Bili:215/4.2, Amylase / Lipase:316/25, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:331 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.0 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   Assesment: This is a 87 yoF w/ cholangitis presenting post ERCP-
   sphincterotomy and stent placement with sphincterotomy bleeding which
   was locally controlled- admitted to [**Hospital Unit Name 10**] for further observation given
   risk of re-bleed.
   Plan:
   #Code Status: Pt is DNR/DNI.  This morning patient is refusing all
   meds, labs, procedures.  The patient states she is ""at peace"" and
   doesn
t want further treatment.  Will talk with son this AM.
   - will discuss with son regarding patient's refusal for care, pt
   requested we speak with him.
   - further workup and eval pending patient
s decision to stop care.
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has
   continued episodes of melanotic stool.  Pt was transfused 1U pRBC due
   to progressively decreasing Hct. Hemodynamically the patient has been
   stable.  Likely continued bleeding from ERCP site. INR and PTT wnl.
   However, the patient is currently refusing all meds, lab work and
   proceudres.
   - will discuss IR embolization if patient continues to bleed and
   require transfusions.
   - f/u ERCP recs
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - NPO
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   - IV PPI
   .
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.   Pt started on Vanco post
   procedure yesterday due to hypotension and hypothermia post proceudre.
   Was switched to Amp yesterday.  LFT and Amylase not drawn today. Pt at
   risk for post-ERCP pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - remain NPO
   -goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis.  Pt refused labs this
   AM
   Negative hepatitis serology.
   - will attempt to trend LFTs and pancreatic enzymes
   .
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   -Pt currently refusing blood draws.
   .
   # HTN: Pt was  hypertensive and given 10mg labetolol x 1 yesterday ,pt
   asymptomatic.   Home med is atenolol, but will use lopressor for
   shorting acting [**Doctor Last Name 23**] given risk of bleed.   Pt does not want BP
   medications.
   -Cont captopril and will increase lopressor 25mg TID..
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet when able to eat.  1/2 dose lantus while npo and
   RISS and q6hr finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  ICU level of care
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:  ISS
   Lines:
   18 Gauge - [**2107-10-31**] 11:02 PM
   20 Gauge - [**2107-11-2**] 10:09 AM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following potential medical complications can arise:

1. Continued bleeding from the ERCP site: The patient has had two episodes of melanotic stool and has required transfusions. The patient is at risk of continued bleeding, which could lead to hypovolemic shock and organ failure.
2. Cholangitis: The patient has a history of cholangitis, and the ERCP procedure may have exacerbated the condition. The patient is at risk of developing sepsis and multi-organ failure if the infection is not effectively managed.
3. Post-ERCP pancreatitis: The patient is at risk of developing pancreatitis due to the ERCP procedure, which could lead to severe abdominal pain, nausea, and vomiting.
4. Thrombocytopenia: The patient has received multiple transfusions, which may have contributed to thrombocytopenia. The patient is at risk of bleeding complications if the platelet count does not improve.
5. Hyperglycemia: The patient has a history of diabetes and is at risk of developing hyperglycemia due to the stress of the hospitalization and the ERCP procedure.
6. Electrolyte imbalance: The patient's electrolyte levels, particularly potassium and phosphorus, are abnormal. The patient is at risk of developing electrolyte imbalances, which could lead to cardiac arrhythmias and other complications.
7. Renal insufficiency: The patient's creatinine level is elevated, which may indicate renal insufficiency. The patient is at risk of developing acute kidney injury or chronic kidney disease if the condition is not effectively managed.
8. Pulmonary complications: The patient has a history of chronic obstructive pulmonary disease (COPD) and is at risk of developing pulmonary complications, such as pneumonia or acute respiratory distress syndrome (ARDS), due to the ERCP procedure and hospitalization.

In terms of the patient's current status, the patient is refusing further treatment and is at risk of developing complications due to the ERCP procedure. The patient's thrombocytopenia, electrolyte imbalance, and renal insufficiency require close monitoring and management. The patient's hyperglycemia and hyperlipidemia require attention and management to prevent complications. The patient's cholangitis and post-ERCP pancreatitis require effective management to prevent sepsis and multi-organ failure."
165668.0,294776,2107-11-04 07:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint: No complaints
   24 Hour Events:
   - Switched to valsartan, d/c'd ACE-I
   - Otherwise uneventful
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-4**] 12:29 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2107-11-4**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 36.9
C (98.4
   HR: 77 (63 - 89) bpm
   BP: 198/66(100) {157/52(80) - 214/94(119)} mmHg
   RR: 21 (16 - 23) insp/min
   SpO2: 94%
   Heart rhythm: AV Paced
   Height: 63 Inch
                  Total In:
                                                                    888 mL
                                                                    120 mL
   PO:
                                                                    450 mL
                                                                    120 mL
   TF:
   IVF:
                                                                    162 mL
   Blood products:
                                                                    276 mL
   Total out:
                                                                  1,640 mL
                                                                    400 mL
   Urine:
                                                                  1,640 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -752 mL
                                                                   -280 mL
   Respiratory support
   SpO2: 94%
   ABG: ///22/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ,
   No(t) Crackles : , No(t) Bronchial: , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   113 K/uL
   13.0 g/dL
   136 mg/dL
   0.8 mg/dL
   22 mEq/L
   3.7 mEq/L
   17 mg/dL
   110 mEq/L
   138 mEq/L
   36.2 %
   7.2 K/uL
        [image002.jpg]
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
                             [**2107-11-3**]  11:15 AM
                            [**2107-11-4**]  04:52 AM
   WBC
   9.3
   9.6
   8.7
   7.2
   Hct
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   34.7
   36.2
   Plt
   132
   82
   94
   113
   Cr
   1.0
   1.1
   1.0
   0.7
   0.8
   Glucose
   192
   393
   80
   141
   136
   Other labs: PT / PTT / INR:12.9/25.1/1.1, ALT / AST:123/68, Alk Phos /
   T Bili:263/1.8, Amylase / Lipase:71/39, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:248 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.6 mg/dL, PO4:1.9 mg/dL
   Assessment and Plan
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: No complaints
   24 Hour Events:
   - Switched to valsartan, d/c'd ACE-I
   - Otherwise uneventful
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-4**] 12:29 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2107-11-4**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 36.9
C (98.4
   HR: 77 (63 - 89) bpm
   BP: 198/66(100) {157/52(80) - 214/94(119)} mmHg
   RR: 21 (16 - 23) insp/min
   SpO2: 94%
   Heart rhythm: AV Paced
   Height: 63 Inch
                  Total In:
                                                                    888 mL
                                                                    120 mL
   PO:
                                                                    450 mL
                                                                    120 mL
   TF:
   IVF:
                                                                    162 mL
   Blood products:
                                                                    276 mL
   Total out:
                                                                  1,640 mL
                                                                    400 mL
   Urine:
                                                                  1,640 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -752 mL
                                                                   -280 mL
   Respiratory support
   SpO2: 94%
   ABG: ///22/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ,
   No(t) Crackles : , No(t) Bronchial: , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   113 K/uL
   13.0 g/dL
   136 mg/dL
   0.8 mg/dL
   22 mEq/L
   3.7 mEq/L
   17 mg/dL
   110 mEq/L
   138 mEq/L
   36.2 %
   7.2 K/uL
        [image002.jpg]
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
                             [**2107-11-3**]  11:15 AM
                            [**2107-11-4**]  04:52 AM
   WBC
   9.3
   9.6
   8.7
   7.2
   Hct
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   34.7
   36.2
   Plt
   132
   82
   94
   113
   Cr
   1.0
   1.1
   1.0
   0.7
   0.8
   Glucose
   192
   393
   80
   141
   136
   Other labs: PT / PTT / INR:12.9/25.1/1.1, ALT / AST:123/68, Alk Phos /
   T Bili:263/1.8, Amylase / Lipase:71/39, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:248 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.6 mg/dL, PO4:1.9 mg/dL
   Assessment and Plan
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a critically ill individual with no complaints, receiving ICU care. They were switched to valsartan and discontinued ACE-I. The patient has a history of no known drug allergies. Antibiotics were administered, including ampicillin, ciprofloxacin, and metronidazole. The patient's vital signs are stable, with a temperature of 36.9C, heart rate of 77 bpm, and blood pressure of 198/66 mmHg. They are receiving respiratory support and have a SpO2 of 94%. The patient's physical examination reveals no acute distress, and their laboratory results show stable hemoglobin, white blood cell count, and platelet count.

Potential Medical Complications:

1. Infection: The patient is receiving antibiotics, but the risk of infection remains due to their critical illness and prolonged hospitalization.
2. Respiratory failure: The patient's SpO2 is 94%, which is within normal limits, but they are receiving respiratory support, indicating a potential risk of respiratory failure.
3. Cardiac arrhythmias: The patient is in atrioventricular paced rhythm, which may increase the risk of cardiac arrhythmias.
4. Bleeding: The patient's platelet count is stable, but their international normalized ratio (INR) is slightly elevated, indicating a potential risk of bleeding.
5. Hepatic dysfunction: The patient's liver enzymes (ALT and AST) are elevated, indicating potential liver dysfunction.
6. Renal dysfunction: The patient's creatinine level is slightly elevated, indicating potential renal dysfunction.
7. Electrolyte imbalance: The patient's electrolyte levels (potassium, magnesium, and phosphate) are slightly abnormal, indicating a potential risk of electrolyte imbalance.
8. Sepsis: The patient is at risk of developing sepsis due to their critical illness and prolonged hospitalization.

Further evaluation and management are necessary to address these potential complications and optimize the patient's care."
165668.0,294776,2107-11-04 07:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint: No complaints
   24 Hour Events:
   - Switched to valsartan, d/c'd ACE-I
   - Otherwise uneventful
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-4**] 12:29 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2107-11-4**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 36.9
C (98.4
   HR: 77 (63 - 89) bpm
   BP: 198/66(100) {157/52(80) - 214/94(119)} mmHg
   RR: 21 (16 - 23) insp/min
   SpO2: 94%
   Heart rhythm: AV Paced
   Height: 63 Inch
                  Total In:
                                                                    888 mL
                                                                    120 mL
   PO:
                                                                    450 mL
                                                                    120 mL
   TF:
   IVF:
                                                                    162 mL
   Blood products:
                                                                    276 mL
   Total out:
                                                                  1,640 mL
                                                                    400 mL
   Urine:
                                                                  1,640 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -752 mL
                                                                   -280 mL
   Respiratory support
   SpO2: 94%
   ABG: ///22/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ,
   No(t) Crackles : , No(t) Bronchial: , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   113 K/uL
   13.0 g/dL
   136 mg/dL
   0.8 mg/dL
   22 mEq/L
   3.7 mEq/L
   17 mg/dL
   110 mEq/L
   138 mEq/L
   36.2 %
   7.2 K/uL
        [image002.jpg]
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
                             [**2107-11-3**]  11:15 AM
                            [**2107-11-4**]  04:52 AM
   WBC
   9.3
   9.6
   8.7
   7.2
   Hct
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   34.7
   36.2
   Plt
   132
   82
   94
   113
   Cr
   1.0
   1.1
   1.0
   0.7
   0.8
   Glucose
   192
   393
   80
   141
   136
   Other labs: PT / PTT / INR:12.9/25.1/1.1, ALT / AST:123/68, Alk Phos /
   T Bili:263/1.8, Amylase / Lipase:71/39, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:248 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.6 mg/dL, PO4:1.9 mg/dL
   Assessment and Plan
   87 yoF w/ cholangitis presenting post ERCP- sphincterotomy and stent
   placement with sphincterotomy bleeding which was locally controlled-
   admitted to [**Hospital Unit Name 10**] for further observation given risk of re-bleed.
   #Code Status: Pt is DNR/DNI. Patient has been refusing all meds, labs,
   procedures, but allowed labs to be drawn this morning.
   - Patient likely to be discharged given recent decision to discontinue
   treatment.
   # HYPERTENSION: Patient has been hypertensive past 24 hours with SBP in
   the 190s. Asymptomatic. Have switched her antihypertensive medications
   back to diovan, which was her home medication. Increased this morning.
   Will continue to monitor. If this returns to within normal limits, then
   she may be able to be discharged.
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has
   continued episodes of melanic stool, but this may represent previous
   bleed from ERCP site moving thru the bowel and not current bleeding.
   Hemodynamically the patient has been stable.  INR and PTT wnl.  HCT
   improved at 36.2.
   - Patient to follow up with ERCP in [**7-3**] weeks
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  On ampicillin due to
   hypotension/hypothermia post op.  Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis. Improving. Negative
   hepatitis serology.
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   Improving
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet.  1/2 dose lantus while npo and RISS and q6hr
   finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  Home today.
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: No complaints
   24 Hour Events:
   - Switched to valsartan, d/c'd ACE-I
   - Otherwise uneventful
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-4**] 12:29 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2107-11-4**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 36.9
C (98.4
   HR: 77 (63 - 89) bpm
   BP: 198/66(100) {157/52(80) - 214/94(119)} mmHg
   RR: 21 (16 - 23) insp/min
   SpO2: 94%
   Heart rhythm: AV Paced
   Height: 63 Inch
                  Total In:
                                                                    888 mL
                                                                    120 mL
   PO:
                                                                    450 mL
                                                                    120 mL
   TF:
   IVF:
                                                                    162 mL
   Blood products:
                                                                    276 mL
   Total out:
                                                                  1,640 mL
                                                                    400 mL
   Urine:
                                                                  1,640 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -752 mL
                                                                   -280 mL
   Respiratory support
   SpO2: 94%
   ABG: ///22/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ,
   No(t) Crackles : , No(t) Bronchial: , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   113 K/uL
   13.0 g/dL
   136 mg/dL
   0.8 mg/dL
   22 mEq/L
   3.7 mEq/L
   17 mg/dL
   110 mEq/L
   138 mEq/L
   36.2 %
   7.2 K/uL
        [image002.jpg]
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
                             [**2107-11-3**]  11:15 AM
                            [**2107-11-4**]  04:52 AM
   WBC
   9.3
   9.6
   8.7
   7.2
   Hct
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   34.7
   36.2
   Plt
   132
   82
   94
   113
   Cr
   1.0
   1.1
   1.0
   0.7
   0.8
   Glucose
   192
   393
   80
   141
   136
   Other labs: PT / PTT / INR:12.9/25.1/1.1, ALT / AST:123/68, Alk Phos /
   T Bili:263/1.8, Amylase / Lipase:71/39, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:248 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.6 mg/dL, PO4:1.9 mg/dL
   Assessment and Plan
   87 yoF w/ cholangitis presenting post ERCP- sphincterotomy and stent
   placement with sphincterotomy bleeding which was locally controlled-
   admitted to [**Hospital Unit Name 10**] for further observation given risk of re-bleed.
   #Code Status: Pt is DNR/DNI. Patient has been refusing all meds, labs,
   procedures, but allowed labs to be drawn this morning.
   - Patient likely to be discharged given recent decision to discontinue
   treatment.
   # HYPERTENSION: Patient has been hypertensive past 24 hours with SBP in
   the 190s. Asymptomatic. Have switched her antihypertensive medications
   back to diovan, which was her home medication. Increased this morning.
   Will continue to monitor. If this returns to within normal limits, then
   she may be able to be discharged.
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has
   continued episodes of melanic stool, but this may represent previous
   bleed from ERCP site moving thru the bowel and not current bleeding.
   Hemodynamically the patient has been stable.  INR and PTT wnl.  HCT
   improved at 36.2.
   - Patient to follow up with ERCP in [**7-3**] weeks
   -trend hct q6hrs, transfuse for hct of < 25
   -maintain active type and screen
   - hemodynamic monitoring.
   -2 large bore IVs
   -given risk of bleed will hold sc heparin
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  On ampicillin due to
   hypotension/hypothermia post op.  Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - goal UOP > 30cc/hr
   -monitor HR and BP
   -check daily LFT and pancreatic enzymes
   - f/u with ERCP recs
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis. Improving. Negative
   hepatitis serology.
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   Improving
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet.  1/2 dose lantus while npo and RISS and q6hr
   finger sticks, hold metformin as inpatient.
   .
   # FEN:  NPO, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  Home today.
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 87-year-old female with cholangitis, sphincterotomy bleeding, and multiple comorbidities, including hypertension, hyperlipidemia, and type II diabetes. She has been admitted to the ICU for further observation and management.

The patient's current vital signs are:

* Temperature: 37.2C (99F)
* Heart rate: 77 beats per minute (bpm)
* Blood pressure: 198/66 mmHg
* Respiratory rate: 21 breaths per minute
* Oxygen saturation: 94%

The patient's laboratory results show:

* White blood cell count: 9.3 x 10^9/L
* Hemoglobin: 23.4 g/dL
* Platelet count: 132 x 10^9/L
* Creatinine: 1.0 mg/dL
* Glucose: 192 mg/dL
* Albumin: 3.0 g/dL
* Calcium: 8.1 mg/dL
* Magnesium: 1.6 mg/dL
* Phosphate: 1.9 mg/dL

The patient's medical conditions include:

* Cholangitis: s/p ERCP with sphincterotomy and stent placement
* Sphincterotomy bleeding: locally controlled, but with ongoing episodes of melanic stool
* Hypertension: asymptomatic, with SBP in the 190s
* Hyperlipidemia: hold lipitor in setting of transaminitis
* Type II diabetes: diabetic diet, 1/2 dose lantus while NPO and RISS, and q6hr finger sticks

The patient's plan of care includes:

* Continue antibiotics (ampicillin, ciprofloxacin, and metronidazole) for cholangitis
* Monitor hemodynamic parameters and transfuse for HCT < 25
* Maintain active type and screen
* Hemodynamic monitoring
* Two large bore IVs
* Hold sc heparin given risk of bleed
* Follow up with ERCP in 7 weeks
* Trend HCT q6hrs
* Monitor HR and BP
* Check daily LFT and pancreatic enzymes
* Follow up with ERCP recommendations
* Follow up blood cultures

Potential medical complications that can arise include:

* Post-ERCP pancreatitis
* Bleeding from sphincterotomy site
* Hypertensive crisis
* Hyperglycemia
* Infection (bacterial or fungal)
* Thrombocytopenia
* Transaminitis
* Electrolyte imbalances (e.g., hypocalcemia, hypomagnesemia)
* Fluid overload

Based on the patient's current condition and plan of care, it is essential to closely monitor her vital signs, laboratory results, and medical conditions to prevent or manage potential complications."
165668.0,294776,2107-11-04 12:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint: No complaints
   24 Hour Events:
   - Patient to continued to be hypertensive in the 190s. ACE inhibitor
   discontinued. Started on Valsartan 80mg. Received 3 doses of
   Hydralazine overnight.
   - Valsartan increased to 160mg in AM with decrease in BP from 190s to
   140s.
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-4**] 12:29 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2107-11-4**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 36.9
C (98.4
   HR: 77 (63 - 89) bpm
   BP: 198/66(100) {157/52(80) - 214/94(119)} mmHg
   RR: 21 (16 - 23) insp/min
   SpO2: 94%
   Heart rhythm: AV Paced
   Height: 63 Inch
                  Total In:
                                                                    888 mL
                                                                    120 mL
   PO:
                                                                    450 mL
                                                                    120 mL
   TF:
   IVF:
                                                                    162 mL
   Blood products:
                                                                    276 mL
   Total out:
                                                                  1,640 mL
                                                                    400 mL
   Urine:
                                                                  1,640 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -752 mL
                                                                   -280 mL
   Respiratory support
   SpO2: 94%
   ABG: ///22/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ,
   No(t) Crackles : , No(t) Bronchial: , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   113 K/uL
   13.0 g/dL
   136 mg/dL
   0.8 mg/dL
   22 mEq/L
   3.7 mEq/L
   17 mg/dL
   110 mEq/L
   138 mEq/L
   36.2 %
   7.2 K/uL
        [image002.jpg]
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
                             [**2107-11-3**]  11:15 AM
                            [**2107-11-4**]  04:52 AM
   WBC
   9.3
   9.6
   8.7
   7.2
   Hct
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   34.7
   36.2
   Plt
   132
   82
   94
   113
   Cr
   1.0
   1.1
   1.0
   0.7
   0.8
   Glucose
   192
   393
   80
   141
   136
   Other labs: PT / PTT / INR:12.9/25.1/1.1, ALT / AST:123/68, Alk Phos /
   T Bili:263/1.8, Amylase / Lipase:71/39, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:248 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.6 mg/dL, PO4:1.9 mg/dL
   Assessment and Plan
   87 yoF w/ cholangitis presenting post ERCP- sphincterotomy and stent
   placement with sphincterotomy bleeding which was locally controlled-
   admitted to [**Hospital Unit Name 10**] for further observation given risk of re-bleed.
   # HYPERTENSION: Patient has been hypertensive past 24 hours with SBP in
   the 190s. Asymptomatic. Have switched her antihypertensive medications
   back to diovan, which was her home medication with an increase in dose
   this morning. BP responded. Will continue to monitor.
   - Will continue Diovan 160mg PO daily
   - Change to Atenolol 25mg PO daily
   - Can callout to floor to continue monitoring BP
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has not
   had any episodes of melanic stool today. Hemodynamically the patient
   has been stable.  INR and PTT wnl.  HCT improved at 36.2.
   - Patient to follow up with ERCP in [**7-3**] weeks
   - hemodynamic monitoring.
   -given risk of bleed will hold sc heparin
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  On ampicillin due to
   hypotension/hypothermia post op.  Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - goal UOP > 30cc/hr
   -monitor HR and BP
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis. Improving. Negative
   hepatitis serology.
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   Improving.
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet.  1/2 dose lantus while npo and RISS and q6hr
   finger sticks, hold metformin as inpatient.
   .
   # FEN:  ADAT, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots. Flu shot.
   Pneumococcal vaccine.
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  Callout today. Screen for skilled nursing facility per PT
   recommendations.
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition: ADAT
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Prophylaxis:
   DVT: Venodyne Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition: Callout
   13:11
   ------ Protected Section ------
   Critical care
   Present for key portions of history and exam. Agree with plan outlined.
   Bleeding seems to have stopped and now is stable.
   Time spent 30 min
   ------ Protected Section Addendum Entered By:[**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**Last Name (NamePattern1) **], MD
   on:[**2107-11-4**] 15:43 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: No complaints
   24 Hour Events:
   - Patient to continued to be hypertensive in the 190s. ACE inhibitor
   discontinued. Started on Valsartan 80mg. Received 3 doses of
   Hydralazine overnight.
   - Valsartan increased to 160mg in AM with decrease in BP from 190s to
   140s.
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-4**] 12:29 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2107-11-4**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 36.9
C (98.4
   HR: 77 (63 - 89) bpm
   BP: 198/66(100) {157/52(80) - 214/94(119)} mmHg
   RR: 21 (16 - 23) insp/min
   SpO2: 94%
   Heart rhythm: AV Paced
   Height: 63 Inch
                  Total In:
                                                                    888 mL
                                                                    120 mL
   PO:
                                                                    450 mL
                                                                    120 mL
   TF:
   IVF:
                                                                    162 mL
   Blood products:
                                                                    276 mL
   Total out:
                                                                  1,640 mL
                                                                    400 mL
   Urine:
                                                                  1,640 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -752 mL
                                                                   -280 mL
   Respiratory support
   SpO2: 94%
   ABG: ///22/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ,
   No(t) Crackles : , No(t) Bronchial: , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   113 K/uL
   13.0 g/dL
   136 mg/dL
   0.8 mg/dL
   22 mEq/L
   3.7 mEq/L
   17 mg/dL
   110 mEq/L
   138 mEq/L
   36.2 %
   7.2 K/uL
        [image002.jpg]
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
                             [**2107-11-3**]  11:15 AM
                            [**2107-11-4**]  04:52 AM
   WBC
   9.3
   9.6
   8.7
   7.2
   Hct
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   34.7
   36.2
   Plt
   132
   82
   94
   113
   Cr
   1.0
   1.1
   1.0
   0.7
   0.8
   Glucose
   192
   393
   80
   141
   136
   Other labs: PT / PTT / INR:12.9/25.1/1.1, ALT / AST:123/68, Alk Phos /
   T Bili:263/1.8, Amylase / Lipase:71/39, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:248 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.6 mg/dL, PO4:1.9 mg/dL
   Assessment and Plan
   87 yoF w/ cholangitis presenting post ERCP- sphincterotomy and stent
   placement with sphincterotomy bleeding which was locally controlled-
   admitted to [**Hospital Unit Name 10**] for further observation given risk of re-bleed.
   # HYPERTENSION: Patient has been hypertensive past 24 hours with SBP in
   the 190s. Asymptomatic. Have switched her antihypertensive medications
   back to diovan, which was her home medication with an increase in dose
   this morning. BP responded. Will continue to monitor.
   - Will continue Diovan 160mg PO daily
   - Change to Atenolol 25mg PO daily
   - Can callout to floor to continue monitoring BP
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has not
   had any episodes of melanic stool today. Hemodynamically the patient
   has been stable.  INR and PTT wnl.  HCT improved at 36.2.
   - Patient to follow up with ERCP in [**7-3**] weeks
   - hemodynamic monitoring.
   -given risk of bleed will hold sc heparin
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  On ampicillin due to
   hypotension/hypothermia post op.  Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - goal UOP > 30cc/hr
   -monitor HR and BP
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis. Improving. Negative
   hepatitis serology.
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   Improving.
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet.  1/2 dose lantus while npo and RISS and q6hr
   finger sticks, hold metformin as inpatient.
   .
   # FEN:  ADAT, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots. Flu shot.
   Pneumococcal vaccine.
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  Callout today. Screen for skilled nursing facility per PT
   recommendations.
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition: ADAT
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Prophylaxis:
   DVT: Venodyne Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition: Callout
   13:11
   ------ Protected Section ------
   Critical care
   Present for key portions of history and exam. Agree with plan outlined.
   Bleeding seems to have stopped and now is stable.
   Time spent 30 min
   ------ Protected Section Addendum Entered By:[**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**Last Name (NamePattern1) **], MD
   on:[**2107-11-4**] 15:43 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the patient is an 87-year-old female who presented with cholangitis after ERCP and sphincterotomy, with subsequent sphincterotomy bleeding that was locally controlled. She was admitted to the ICU for further observation due to the risk of re-bleed.

The patient has been hypertensive, with a systolic blood pressure in the 190s, and has been switched to Diovan 160mg PO daily, with an increase in dose this morning, which has responded well. She is also at risk for post-ERCP pancreatitis.

The patient has had episodes of GI bleed, which have been locally controlled, and has not had any episodes of melanic stool today. Her INR and PTT are within normal limits, and her HCT has improved to 36.2.

The patient has also been experiencing thrombocytopenia, which is likely due to dilutional thrombocytopenia from multiple transfusions and consumption from bleeding. Her platelet count is improving.

The patient has been started on antibiotics for cholangitis, and her transaminase elevation is improving. She is at risk for post-ERCP pancreatitis, and her blood glucose levels are being monitored.

The patient has a history of CAD, but there are no active issues at present. She is also at risk for b12 deficiency and hyperlipidemia.

The patient's code status is DNR/DNI, and her disposition is callout with a plan to screen for a skilled nursing facility.

Potential medical complications that can arise include:

* Continued hypertension, which could lead to cardiovascular complications
* Post-ERCP pancreatitis, which could lead to abdominal pain, nausea, and vomiting
* Thrombocytopenia, which could lead to bleeding complications
* Cholangitis, which could lead to sepsis and multi-organ failure
* B12 deficiency, which could lead to neurological symptoms
* Hyperlipidemia, which could lead to cardiovascular complications
* Diabetes, which could lead to hyperglycemia and its complications

The patient's plan of care includes continuing antibiotics for cholangitis, monitoring her blood glucose levels, and adjusting her antihypertensive medications as needed. She will also be monitored for signs of post-ERCP pancreatitis and thrombocytopenia."
165668.0,294776,2107-11-04 12:39:00,Physician ,Physician Resident Progress Note,"Chief Complaint: No complaints
   24 Hour Events:
   - Patient to continued to be hypertensive in the 190s. ACE inhibitor
   discontinued. Started on Valsartan 80mg. Received 3 doses of
   Hydralazine overnight.
   - Valsartan increased to 160mg in AM with decrease in BP from 190s to
   140s.
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-4**] 12:29 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2107-11-4**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 36.9
C (98.4
   HR: 77 (63 - 89) bpm
   BP: 198/66(100) {157/52(80) - 214/94(119)} mmHg
   RR: 21 (16 - 23) insp/min
   SpO2: 94%
   Heart rhythm: AV Paced
   Height: 63 Inch
                  Total In:
                                                                    888 mL
                                                                    120 mL
   PO:
                                                                    450 mL
                                                                    120 mL
   TF:
   IVF:
                                                                    162 mL
   Blood products:
                                                                    276 mL
   Total out:
                                                                  1,640 mL
                                                                    400 mL
   Urine:
                                                                  1,640 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -752 mL
                                                                   -280 mL
   Respiratory support
   SpO2: 94%
   ABG: ///22/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ,
   No(t) Crackles : , No(t) Bronchial: , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   113 K/uL
   13.0 g/dL
   136 mg/dL
   0.8 mg/dL
   22 mEq/L
   3.7 mEq/L
   17 mg/dL
   110 mEq/L
   138 mEq/L
   36.2 %
   7.2 K/uL
        [image002.jpg]
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
                             [**2107-11-3**]  11:15 AM
                            [**2107-11-4**]  04:52 AM
   WBC
   9.3
   9.6
   8.7
   7.2
   Hct
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   34.7
   36.2
   Plt
   132
   82
   94
   113
   Cr
   1.0
   1.1
   1.0
   0.7
   0.8
   Glucose
   192
   393
   80
   141
   136
   Other labs: PT / PTT / INR:12.9/25.1/1.1, ALT / AST:123/68, Alk Phos /
   T Bili:263/1.8, Amylase / Lipase:71/39, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:248 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.6 mg/dL, PO4:1.9 mg/dL
   Assessment and Plan
   87 yoF w/ cholangitis presenting post ERCP- sphincterotomy and stent
   placement with sphincterotomy bleeding which was locally controlled-
   admitted to [**Hospital Unit Name 10**] for further observation given risk of re-bleed.
   # HYPERTENSION: Patient has been hypertensive past 24 hours with SBP in
   the 190s. Asymptomatic. Have switched her antihypertensive medications
   back to diovan, which was her home medication with an increase in dose
   this morning. BP responded. Will continue to monitor.
   - Will continue Diovan 160mg PO daily
   - Change to Atenolol 25mg PO daily
   - Can callout to floor to continue monitoring BP
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has not
   had any episodes of melanic stool today. Hemodynamically the patient
   has been stable.  INR and PTT wnl.  HCT improved at 36.2.
   - Patient to follow up with ERCP in [**7-3**] weeks
   - hemodynamic monitoring.
   -given risk of bleed will hold sc heparin
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  On ampicillin due to
   hypotension/hypothermia post op.  Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - goal UOP > 30cc/hr
   -monitor HR and BP
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis. Improving. Negative
   hepatitis serology.
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   Improving.
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet.  1/2 dose lantus while npo and RISS and q6hr
   finger sticks, hold metformin as inpatient.
   .
   # FEN:  ADAT, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots. Flu shot.
   Pneumococcal vaccine.
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  Callout today. Screen for skilled nursing facility per PT
   recommendations.
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition: ADAT
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Prophylaxis:
   DVT: Venodyne Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition: Callout
   13:11
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: No complaints
   24 Hour Events:
   - Patient to continued to be hypertensive in the 190s. ACE inhibitor
   discontinued. Started on Valsartan 80mg. Received 3 doses of
   Hydralazine overnight.
   - Valsartan increased to 160mg in AM with decrease in BP from 190s to
   140s.
   History obtained from Patient
   Allergies:
   History obtained from PatientNo Known Drug Allergies
   Last dose of Antibiotics:
   Ampicillin - [**2107-11-2**] 08:02 PM
   Ciprofloxacin - [**2107-11-2**] 08:02 PM
   Metronidazole - [**2107-11-4**] 12:29 AM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Dyspnea
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2107-11-4**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 36.9
C (98.4
   HR: 77 (63 - 89) bpm
   BP: 198/66(100) {157/52(80) - 214/94(119)} mmHg
   RR: 21 (16 - 23) insp/min
   SpO2: 94%
   Heart rhythm: AV Paced
   Height: 63 Inch
                  Total In:
                                                                    888 mL
                                                                    120 mL
   PO:
                                                                    450 mL
                                                                    120 mL
   TF:
   IVF:
                                                                    162 mL
   Blood products:
                                                                    276 mL
   Total out:
                                                                  1,640 mL
                                                                    400 mL
   Urine:
                                                                  1,640 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -752 mL
                                                                   -280 mL
   Respiratory support
   SpO2: 94%
   ABG: ///22/
   Physical Examination
   General Appearance: No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), (Murmur: No(t) Systolic,
   No(t) Diastolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Present), (Left DP pulse:
   Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ,
   No(t) Crackles : , No(t) Bronchial: , No(t) Wheezes : , No(t)
   Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Not assessed
   Labs / Radiology
   113 K/uL
   13.0 g/dL
   136 mg/dL
   0.8 mg/dL
   22 mEq/L
   3.7 mEq/L
   17 mg/dL
   110 mEq/L
   138 mEq/L
   36.2 %
   7.2 K/uL
        [image002.jpg]
                             [**2107-10-31**]  09:54 PM
                             [**2107-11-1**]  04:29 AM
                             [**2107-11-1**]  12:54 PM
                             [**2107-11-1**]  10:42 PM
                             [**2107-11-2**]  04:44 AM
                             [**2107-11-2**]  02:09 PM
                             [**2107-11-2**]  04:30 PM
                             [**2107-11-3**]  12:07 AM
                             [**2107-11-3**]  11:15 AM
                            [**2107-11-4**]  04:52 AM
   WBC
   9.3
   9.6
   8.7
   7.2
   Hct
   23.4
   30.8
   21.1
   26.7
   25.5
   30.0
   30.7
   28.4
   34.7
   36.2
   Plt
   132
   82
   94
   113
   Cr
   1.0
   1.1
   1.0
   0.7
   0.8
   Glucose
   192
   393
   80
   141
   136
   Other labs: PT / PTT / INR:12.9/25.1/1.1, ALT / AST:123/68, Alk Phos /
   T Bili:263/1.8, Amylase / Lipase:71/39, Differential-Neuts:89.5 %,
   Lymph:8.2 %, Mono:2.1 %, Eos:0.1 %, Albumin:3.0 g/dL, LDH:248 IU/L,
   Ca++:8.1 mg/dL, Mg++:1.6 mg/dL, PO4:1.9 mg/dL
   Assessment and Plan
   87 yoF w/ cholangitis presenting post ERCP- sphincterotomy and stent
   placement with sphincterotomy bleeding which was locally controlled-
   admitted to [**Hospital Unit Name 10**] for further observation given risk of re-bleed.
   # HYPERTENSION: Patient has been hypertensive past 24 hours with SBP in
   the 190s. Asymptomatic. Have switched her antihypertensive medications
   back to diovan, which was her home medication with an increase in dose
   this morning. BP responded. Will continue to monitor.
   - Will continue Diovan 160mg PO daily
   - Change to Atenolol 25mg PO daily
   - Can callout to floor to continue monitoring BP
   # GI BLEED: s/p ERCP and sphincterotomy.  The patient has had to return
   for repeat cautery twice since initial procedure.  The patient has not
   had any episodes of melanic stool today. Hemodynamically the patient
   has been stable.  INR and PTT wnl.  HCT improved at 36.2.
   - Patient to follow up with ERCP in [**7-3**] weeks
   - hemodynamic monitoring.
   -given risk of bleed will hold sc heparin
   # Cholangitis: s/p ERCP with a sphincterotomy and stent placment for
   cholangitis, stones in the common bile duct.  On ampicillin due to
   hypotension/hypothermia post op.  Pt at risk for post-ERCP
   pancreatitis.
   -continue antibiotics cipro / flagyl
   - Cont amp
   - goal UOP > 30cc/hr
   -monitor HR and BP
   - f/u blood cx
   .
   # Transaminase elevation: likely [**2-26**] cholangitis. Improving. Negative
   hepatitis serology.
   #Thrombocytopenia: Dilutional [**2-26**] multiple transfusions and
   conspumption from bleeding.  Possible contribution from vanco.
   Improving.
   # CAD: no active issues.  Hold ASA and lipitor.
   -monitor on tele
   .
   # b12 deficiency- cont 1000 mcg b12, levels were normal.
   .
   # Hyperlipidemia: hold lipitor in setting of transaminitis.
   .
   # DMII: diabetic diet.  1/2 dose lantus while npo and RISS and q6hr
   finger sticks, hold metformin as inpatient.
   .
   # FEN:  ADAT, PPI
   .
   # Access: PIV
   .
   # PPx:  PPI [**Hospital1 **], hold sc heparin given bleed, pneumoboots. Flu shot.
   Pneumococcal vaccine.
   .
   # Code:  DNR/I confirmed with patient
   .
   # Dispo:  Callout today. Screen for skilled nursing facility per PT
   recommendations.
   .
   # Comm: HCP [**Name (NI) **] [**Name (NI) 1130**]  (son) [**Telephone/Fax (1) 1131**]
   ICU Care
   Nutrition: ADAT
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Prophylaxis:
   DVT: Venodyne Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition: Callout
   13:11<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 87-year-old female admitted to the ICU for further observation after undergoing ERCP with sphincterotomy and stent placement for cholangitis. She has been experiencing hypertension, with a blood pressure in the 190s, and has been treated with antihypertensive medications. She has also had a history of gastrointestinal bleeding, which has been locally controlled. The patient's laboratory results show evidence of cholangitis, with elevated liver enzymes and a slightly decreased platelet count. She has also been diagnosed with thrombocytopenia, likely due to dilutional causes and consumption from bleeding.

Potential Medical Complications:

1. Hypertension: The patient's hypertension may lead to complications such as cardiac arrhythmias, stroke, or kidney damage if not properly managed.
2. Gastrointestinal Bleeding: The patient's history of gastrointestinal bleeding may lead to further bleeding complications, including hemorrhagic shock, if not properly managed.
3. Cholangitis: The patient's cholangitis may lead to further complications such as sepsis, liver failure, or pancreatitis if not properly managed.
4. Thrombocytopenia: The patient's thrombocytopenia may lead to further bleeding complications if not properly managed.
5. Transaminase Elevation: The patient's transaminase elevation may be a sign of liver damage or cholestasis, which may lead to further complications if not properly managed.
6. CAD: The patient's history of CAD may lead to further complications such as myocardial infarction or cardiac arrhythmias if not properly managed.
7. B12 Deficiency: The patient's B12 deficiency may lead to further complications such as neurological symptoms or anemia if not properly managed.
8. Hyperlipidemia: The patient's hyperlipidemia may lead to further complications such as pancreatitis or cardiovascular disease if not properly managed.
9. DMII: The patient's DMII may lead to further complications such as ketoacidosis or hyperosmolar hyperglycemic nonketotic syndrome if not properly managed.

Based on the patient's medical history and laboratory results, it is recommended that she continue to receive close monitoring and management for her hypertension, gastrointestinal bleeding, cholangitis, thrombocytopenia, transaminase elevation, CAD, B12 deficiency, hyperlipidemia, and DMII."
